TW201923043A - Liquid crystal medium and liquid crystal device - Google Patents

Liquid crystal medium and liquid crystal device Download PDF

Info

Publication number
TW201923043A
TW201923043A TW107137466A TW107137466A TW201923043A TW 201923043 A TW201923043 A TW 201923043A TW 107137466 A TW107137466 A TW 107137466A TW 107137466 A TW107137466 A TW 107137466A TW 201923043 A TW201923043 A TW 201923043A
Authority
TW
Taiwan
Prior art keywords
formula
groups
coo
compounds
independently
Prior art date
Application number
TW107137466A
Other languages
Chinese (zh)
Inventor
賽門 席密安諾史基
阿拉希 韓森 努魯茲
馬堤亞斯 柏爾墨
詹納 珍
碧特 史奈德
馬丁 赫納
凱文 凱瑟
Original Assignee
德商馬克專利公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 德商馬克專利公司 filed Critical 德商馬克專利公司
Publication of TW201923043A publication Critical patent/TW201923043A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/02Liquid crystal materials characterised by optical, electrical or physical properties of the components, in general
    • C09K19/0258Flexoelectric
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/02Liquid crystal materials characterised by optical, electrical or physical properties of the components, in general
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/10Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings
    • C09K19/12Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings at least two benzene rings directly linked, e.g. biphenyls
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/30Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/30Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
    • C09K19/3098Unsaturated non-aromatic rings, e.g. cyclohexene rings
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K2019/0444Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit characterized by a linking chain between rings or ring systems, a bridging chain between extensive mesogenic moieties or an end chain group
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/10Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings
    • C09K19/12Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings at least two benzene rings directly linked, e.g. biphenyls
    • C09K2019/121Compounds containing phenylene-1,4-diyl (-Ph-)
    • C09K2019/123Ph-Ph-Ph
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/30Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
    • C09K19/3001Cyclohexane rings
    • C09K19/3003Compounds containing at least two rings in which the different rings are directly linked (covalent bond)
    • C09K2019/3009Cy-Ph
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/30Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
    • C09K19/3001Cyclohexane rings
    • C09K19/3003Compounds containing at least two rings in which the different rings are directly linked (covalent bond)
    • C09K2019/301Cy-Cy-Ph
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/30Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
    • C09K19/3001Cyclohexane rings
    • C09K19/3003Compounds containing at least two rings in which the different rings are directly linked (covalent bond)
    • C09K2019/3016Cy-Ph-Ph
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/30Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
    • C09K19/3001Cyclohexane rings
    • C09K19/3003Compounds containing at least two rings in which the different rings are directly linked (covalent bond)
    • C09K2019/3027Compounds comprising 1,4-cyclohexylene and 2,3-difluoro-1,4-phenylene

Abstract

The invention relates to a compound of formula I, R11-A11-(Z11-A12)p-X11-Sp11-X12-(A13-Z13)q-A14-R12 I wherein R11, R12, A11 to A14, Z11, Z13, X11, X12, Sp11, p and q have one of the meanings as given herein below. The invention further relates to method of production of a compound of formula I, to the use of said compounds in LC media and to LC media comprising one or more compounds of formula I. Further, the invention relates to a method of production of such LC media, to the use of such media in LC devices, in particular, in flexoelectric LC devices and to a flexoelectric LC device comprising a LC medium according to the present invention.

Description

液晶介質及液晶裝置Liquid crystal medium and liquid crystal device

本發明係關於一種式I之化合物,
R11 -A11 -(Z11 -A12 )p -X11 -Sp11 -X12 -(A13 -Z13 )q -A14 -R12 I
其中R11 、R12 、A11 至A14 、Z11 、Z13 、X11 、X12 、Sp11 、p及q具有下文中所給定之含義中之一者。本發明另外關於一種製備式I之化合物之方法、該等化合物在LC介質中之用途及包含一或多種式I之化合物之LC介質。另外,本發明係關於一種製備此類LC介質之方法、此類介質在LC裝置中,尤其在撓曲電LC裝置中之用途及包含根據本發明之LC介質之撓曲電LC裝置。
The invention relates to a compound of formula I,
R 11 -A 11- (Z 11 -A 12 ) p -X 11 -Sp 11 -X 12- (A 13 -Z 13 ) q -A 14 -R 12 I
Wherein R 11 , R 12 , A 11 to A 14 , Z 11 , Z 13 , X 11 , X 12 , Sp 11 , p and q have one of the meanings given below. The invention further relates to a method for preparing compounds of formula I, their use in LC media and LC media comprising one or more compounds of formula I. In addition, the present invention relates to a method for preparing such an LC medium, the use of such a medium in an LC device, especially in a flex electric LC device, and a flex electric LC device including the LC medium according to the invention.

撓曲電效應由例如Chandrasekhar, 「Liquid Crystals」, 第2版, Cambridge University Press (1992)及P.G. deGennes等人, 「The Physics of Liquid Crystals」, 第2版, Oxford Science Publications (1995)描述。The flexure effect is described by, for example, Chandrasekhar, "Liquid Crystals", 2nd edition, Cambridge University Press (1992) and P.G. deGennes et al., "The Physics of Liquid Crystals", 2nd edition, Oxford Science Publications (1995).

利用撓曲電效應之撓曲電裝置例如ULH裝置及尤其適用於撓曲電裝置之液晶介質自EP 0 971 016、GB 2 356 629及Coles, H.J., Musgrave, B., Coles, M.J.及Willmott, J., J. Mater. Chem., 11, 第2709-2716頁(2001)得知。Flexural electrical devices using flexural electrical effects such as ULH devices and liquid crystal media particularly suitable for flexural electrical devices are from EP 0 971 016, GB 2 356 629 and Coles, HJ, Musgrave, B., Coles, MJ and Willmott, J., J. Mater. Chem., 11, pp. 2709-2716 (2001).

均勻橫向螺旋(Uniform Lying Helix,ULH)很具有作為快速切換液晶顯示模式之潛能。其在35℃下能夠達到亞毫秒之切換且具有固有地較高孔徑比,帶來一種高效節能顯示模式。Uniform Lying Helix (ULH) has the potential as a fast switching LCD display mode. It can achieve sub-millisecond switching at 35 ° C and has an inherently high aperture ratio, bringing an energy-efficient display mode.

常用於適用於ULH模式之介質中之材料通常係雙液晶原。由於該等材料之大小及極性基團,諸如末端氰基之存在,其在35℃下通常具有數千mPa.s數量級之高轉動黏度(γ1 )。在升高之溫度例如35℃下,γ1 值較高不會造成問題,因為切換速度與γ1 成正比。另一方面,γ1值亦與對掌性螺距平方成比例。因為對掌性螺距通常為大約300 nm,此意謂切換速度仍極快,大約1毫秒或幾毫秒。The materials commonly used in media suitable for ULH mode are usually dual mesogens. Due to the size and polar groups of these materials, such as the presence of terminal cyano groups, they typically have high rotational viscosity (γ 1 ) on the order of thousands of mPa.s at 35 ° C. At elevated temperatures, such as 35 ° C, a higher γ 1 value will not cause problems because the switching speed is directly proportional to γ 1 . On the other hand, the value of γ1 is also proportional to the square of the pitch. Because the pitch of the palm is usually about 300 nm, this means that the switching speed is still extremely fast, about 1 millisecond or several milliseconds.

然而,在達到ULH裝置通常運行之較低溫度,諸如室溫時,γ1 之值以指數方式增大且即使在較短螺距材料之情況下切換速度增加超出有利的水準。However, at the lower temperatures at which ULH devices typically operate, such as room temperature, the value of γ 1 increases exponentially and the switching speed increases beyond favorable levels even in the case of shorter pitch materials.

為了在低於35℃之溫度下保持快速切換速度,LC混合物之γ1 值需降低,且因此需要鑑別具有較低γ1 之混合物組分。In order to maintain fast switching speeds at temperatures below 35 ° C, the γ 1 value of the LC mixture needs to be reduced, and therefore it is necessary to identify mixture components with lower γ 1 .

相應地,極需要新型雙液晶原化合物,其展現有利的低γ1 值同時較佳地展現:
· 有利的e/K (V-1 )值,
· 有利的寬向列相範圍及
· 高澄清點。
Accordingly, there is a great need for new dual mesogen compounds that exhibit a favorable low γ 1 value while also exhibiting better:
· Favorable e / K (V -1 ) values,
· Favorable wide nematic phase range and · High clarification point.

除該等要求之外,對應的LC介質應展現有利的低γ1 值同時較佳地展現:
· 低熔點,
· 高澄清點,
· 寬對掌性向列相範圍,
· 短溫度無關螺距長度,
· 高撓曲電係數及
· 有利的低溫穩定性而無單元以及主體中之結晶效應。
In addition to these requirements, the corresponding LC medium should exhibit a favorable low γ 1 value while also exhibiting better:
· Low melting point,
· High clarification points,
· Wide palmar nematic phase range,
· Short temperature independent pitch length,
· High deflection coefficient and · Favorable low temperature stability without cell and crystallization effects in the body.

根據以下詳細描述,本發明之其他目標對熟習此項技術者而言將立即顯而易見。Other objects of the present invention will be immediately apparent to those skilled in the art from the following detailed description.

出乎意料地,本發明人發現上述目標中之一或多個可藉由提供如技術方案1之化合物來達成。Unexpectedly, the present inventors have found that one or more of the above-mentioned objects can be achieved by providing a compound such as the technical scheme 1.

本發明係關於一種式I之化合物,
R11 -A11 (-Z11 -A12 -)p -X11 -Sp11 -X12 -(A13 -Z12 -)q A14 -R12 I
其中
R11 表示NO2 、NCO或NCS
R12 表示F、Cl、CN、NO2 、NCO、NCS或直鏈或分支鏈烷基,該直鏈或分支鏈烷基可為未經取代、經鹵素或CN單取代或多取代的且其中一或多個不相鄰且非末端CH2 基團可在每次出現時彼此獨立地經以下基團置換:-O-、-S-、-NH-、-N(CH3 )-、-CO-、-COO-、-OCO-、-O-CO-O-、-S-CO-、-CO-S-、-CH=CH-、-CH=CF-、-CF=CF-或-C≡C-,置換方式為使得氧原子彼此不直接連接,
較佳為F、Cl、CN、NO2 、NCO、NCS、可未經取代、經鹵素或CN單取代或多取代之直鏈或分支鏈烷基、烯基或烷氧基,
更佳為NO2 、NCO、NCS,
A11 至A14 在每次出現時各自獨立地表示1,4-伸苯基,另外其中一或多個CH基團可經N置換;反-1,4-伸環己基,另外其中一個或兩個不相鄰CH2 基團可經O及/或S置換;1,4-伸環己基;萘-2,6-二基;十氫萘-2,6-二基;1,2,3,4-四氫-萘-2,6-二基,所有該等基團可能為未經取代、經F、Cl、CN或烷基、烷氧基、烷基羰基或烷氧羰基單取代、二取代、三取代或四取代的,其中一或多個H原子可經F或Cl取代,
較佳在每次出現時各自獨立地為1,4-伸苯基,另外其中一或多個CH基團可經N置換;或反-1,4-伸環己基,另外其中一個或兩個不相鄰CH2 基團可經O及/或S置換,兩種環基團皆可能為未經取代、經F、Cl、CN或烷基、烷氧基、烷基羰基或烷氧羰基單取代、二取代、三取代或四取代的,其中一或多個H原子可經F或Cl取代,
Z11 及Z12 在每次出現時彼此獨立地為單鍵、-COO-、-OCO-、-O-CO-O-、-OCH2 -、-CH2 O-、-OCF2 -、-CF2 O-、-CH2 CH2 -、-(CH2 )4 -、-CF2 CF2 -、-CH=CH-、-CF=CF-、-CH=CH-COO-、-OCO-CH=CH-或-C≡C-,該等基團視情況經一或多個F、S及/或Si取代,
較佳為-COO-、-OCO-、-OCF2 -、-CF2 O-或單鍵,
更佳為單鍵,
p及q 各自且獨立地為0、1、2、3或4,較佳為0、1、2或3且最佳為1或2。
Sp11 為間隔基團,其包含1、3或5至40個C原子,其中一或多個不相鄰且非末端CH2 基團亦可經以下基團置換:-O-、-S-、-NH-、-N(CH3 )-、-CO-、-O-CO-、-S-CO-、-O-COO-、-CO-S-、-CO-O-、-CF2 -、-CF2 O-、-OCF2 -、-C(OH)-、-CH(烷基)-、-CH(烯基)-、-CH(烷氧基)-、-CH(氧雜烷基)-、-CH=CH-或-C≡C-,然而置換方式為使得沒有兩個O原子彼此相鄰且沒有兩個選自-O-CO-、-S-CO-、-O-COO-、-CO-S-、-CO-O-及-CH=CH-之基團彼此相鄰,
較佳為-(CH2 )n -,其中n為1、3或來自5至15之整數,更佳為3至11,最佳為奇數整數(亦即3、5、7、9或11),
X11 及X12 彼此獨立地選自單鍵、-CO-O-、-O-CO-、-O-COO-、-O-、-CH=CH-、-C≡C-、-CF2 -O-、-O-CF2 -、-CF2 -CF2 -、-CH2 -O-、-O-CH2 -、-CO-S-、-S-CO-、-CS-S-、-S-CS-、-S-CSS-及-S-,其中在-X11 -Sp1 -X12 -中,兩個O原子、兩個-CH=CH-基團及兩個選自-O-CO-、-S-CO-、-O-COO-、-CO-S-及-CO-O-之基團分別彼此不直接連接,
較佳為-CO-O-、-O-CO-、-O-、-C≡C-、-CF2 -O-、-O-CF2 -或單鍵,
更佳為-CO-O-、-O-CO-或單鍵。
The invention relates to a compound of formula I,
R 11 -A 11 (-Z 11 -A 12- ) p -X 11 -Sp 11 -X 12- (A 13 -Z 12- ) q A 14 -R 12 I
among them
R 11 means NO 2 , NCO or NCS
R 12 represents F, Cl, CN, NO 2 , NCO, NCS or a linear or branched alkyl group, which may be unsubstituted, mono- or poly-substituted with halogen or CN and wherein one or more non-adjacent and non-terminal CH 2 groups may independently be replaced by the following groups to each other in each occurrence: -O -, - S -, - NH -, - N (CH 3) -, - CO-, -COO-, -OCO-, -O-CO-O-, -S-CO-, -CO-S-, -CH = CH-, -CH = CF-, -CF = CF- or- C≡C-, the substitution method is such that the oxygen atoms are not directly connected to each other,
Preferred are F, Cl, CN, NO 2 , NCO, NCS, straight or branched chain alkyl, alkenyl or alkoxy which may be unsubstituted, mono- or poly-substituted with halogen or CN,
More preferably NO 2 , NCO, NCS,
A 11 to A 14 each independently represent 1,4-phenylene, and one or more CH groups may be replaced by N; trans-1,4-cyclohexyl, and one or Two non-adjacent CH 2 groups can be replaced by O and / or S; 1,4-cyclohexyl; naphthalene-2,6-diyl; decahydronaphthalene-2,6-diyl; 1,2, 3,4-tetrahydro-naphthalene-2,6-diyl, all such groups may be unsubstituted, mono-substituted with F, Cl, CN or alkyl, alkoxy, alkylcarbonyl or alkoxycarbonyl , Di-, tri- or tetra-substituted, in which one or more H atoms may be substituted by F or Cl,
Preferably each occurrence is independently 1,4-phenylene, and one or more of the CH groups may be replaced by N; or trans-1,4-cyclohexyl, and one or two of them Non-adjacent CH 2 groups can be replaced by O and / or S. Both ring groups may be unsubstituted, F, Cl, CN or alkyl, alkoxy, alkylcarbonyl or alkoxycarbonyl mono Substituted, disubstituted, trisubstituted or tetrasubstituted, in which one or more H atoms may be substituted by F or Cl,
Z 11 and Z 12 are each independently a single bond, -COO-, -OCO-, -O-CO-O-, -OCH 2- , -CH 2 O-, -OCF 2 -,- CF 2 O-, -CH 2 CH 2 -,-(CH 2 ) 4- , -CF 2 CF 2- , -CH = CH-, -CF = CF-, -CH = CH-COO-, -OCO- CH = CH- or -C≡C-, these groups are optionally substituted by one or more F, S and / or Si,
-COO-, -OCO-, -OCF 2- , -CF 2 O- or a single bond is preferred,
More preferably a single key,
p and q are each independently 0, 1, 2, 3, or 4, preferably 0, 1, 2, or 3, and most preferably 1 or 2.
Sp 11 is a spacer group that contains 1, 3, or 5 to 40 C atoms. One or more non-adjacent and non-terminal CH 2 groups can also be replaced by the following groups: -O-, -S- , -NH-, -N (CH 3 )-, -CO-, -O-CO-, -S-CO-, -O-COO-, -CO-S-, -CO-O-, -CF 2 -, -CF 2 O-, -OCF 2- , -C (OH)-, -CH (alkyl)-, -CH (alkenyl)-, -CH (alkoxy)-, -CH (oxa Alkyl)-, -CH = CH- or -C≡C-, but the substitution is such that no two O atoms are adjacent to each other and no two are selected from -O-CO-, -S-CO-, -O -COO-, -CO-S-, -CO-O- and -CH = CH- are adjacent to each other,
Preferably-(CH 2 ) n- , where n is 1, 3 or an integer from 5 to 15, more preferably 3 to 11, most preferably an odd integer (ie 3, 5, 7, 9 or 11) ,
X 11 and X 12 are independently selected from a single bond, -CO-O-, -O-CO-, -O-COO-, -O-, -CH = CH-, -C≡C-, -CF 2 -O-, -O-CF 2- , -CF 2 -CF 2- , -CH 2 -O-, -O-CH 2- , -CO-S-, -S-CO-, -CS-S- , -S-CS-, -S-CSS-, and -S-, in -X 11 -Sp 1 -X 12- , two O atoms, two -CH = CH- groups, and two selected from The groups of -O-CO-, -S-CO-, -O-COO-, -CO-S-, and -CO-O- are not directly connected to each other,
-CO-O-, -O-CO-, -O-, -C≡C-, -CF 2 -O-, -O-CF 2 -or a single bond,
More preferably, it is -CO-O-, -O-CO-, or a single bond.

術語及定義Terms and definitions

術語「液晶」、「介晶化合物」或「液晶原化合物」(亦簡稱為「液晶原」)意謂在適合之溫度、壓力及濃度條件下可以介晶相(向列型、近晶型等)或尤其以LC相存在之化合物。非兩親液晶原基化合物包含例如一或多種棒狀、香蕉形或盤狀液晶原基團。The terms "liquid crystal", "mesogenic compound" or "mesogen" (also referred to as "mesogen") mean that the mesogenic phase (nematic, smectic, etc.) can be used under suitable temperature, pressure and concentration conditions. ) Or compounds which exist especially in the LC phase. Non-amphiphilic mesogens include, for example, one or more rod-shaped, banana-shaped, or disc-shaped mesogens.

術語「液晶原基團」在此上下文中意謂具有誘導液晶(LC)相特性之能力的基團。包含液晶原基團之化合物本身不必展現LC相。亦有可能,其僅在與其他化合物之混合物中展示LC相特性。為簡潔起見,術語「液晶」在下文中係用於液晶原材料及LC材料兩者。The term "mesogen" means a group having the ability to induce liquid crystal (LC) phase characteristics in this context. The compound containing the mesogen group itself need not exhibit an LC phase. It is also possible that it exhibits LC phase characteristics only in mixtures with other compounds. For the sake of brevity, the term "liquid crystal" is used hereinafter for both liquid crystal raw materials and LC materials.

在本申請案全篇中,除非明確陳述,否則術語「芳基及雜芳基」涵蓋基團,該等基團可為單環或多環,亦即其可具有一個環(諸如苯基)或兩個或更多環,其亦可為稠合的(諸如萘基)或共價連接的(諸如聯二苯)或含有稠環及連接環。Throughout this application, unless explicitly stated otherwise, the term "aryl and heteroaryl" encompasses groups, which may be monocyclic or polycyclic, that is, they may have one ring (such as phenyl) Or two or more rings, which may also be fused (such as naphthyl) or covalently linked (such as biphenyl) or contain fused and linked rings.

雜芳基含有一或多個較佳選自O、N、S及Se之雜原子。尤其較佳為具有6至25個C原子之單環、二環或三環芳基及具有2至25個C原子之單環、二環或三環雜芳基,其視情況含有稠環且視情況經取代。此外,較佳為5員、6員或7員芳基及雜芳基,另外,其中一或多個CH基團可以使得O原子及/或S原子彼此不直接連接之方式經N、S或O置換。較佳芳基為例如苯基、聯二苯、聯三苯、[1,1':3',1'']聯三苯-2'-基、萘基、蒽、聯萘、菲、芘、二氫芘、䓛、苝、并四苯、稠五苯、苯并芘、茀、茚、茚并茀、螺二茀,更佳為1,4-伸苯基、4,4'-伸聯苯基、1,4-伸聯三苯基。Heteroaryl contains one or more heteroatoms preferably selected from O, N, S and Se. Especially preferred are monocyclic, bicyclic or tricyclic aryl groups having 6 to 25 C atoms and monocyclic, bicyclic or tricyclic heteroaryl groups having 2 to 25 C atoms, which optionally contain a fused ring and Replaced as appropriate. In addition, a 5-membered, 6-membered or 7-membered aryl group and a heteroaryl group are preferred. In addition, one or more CH groups may pass through N, S or O substitution. Preferred aryl groups are, for example, phenyl, biphenyl, bitriphenyl, [1,1 ': 3', 1 ''] bitriphenyl-2'-yl, naphthyl, anthracene, binaphthyl, phenanthrene, fluorene , Dihydropyrene, pyrene, pyrene, tetracene, pentacene, benzofluorene, pyrene, indene, indenofluorene, spirobifluorene, more preferably 1,4-phenylene, 4,4'-phenylene Biphenyl, 1,4-triphenylene.

較佳雜芳基為例如5員環,諸如吡咯、吡唑、咪唑、1,2,3-三唑、1,2,4-三唑、四唑、呋喃、噻吩、硒吩、噁唑、異噁唑、1,2-噻唑、1,3-噻唑、1,2,3-噁二唑、1,2,4-噁二唑、1,2,5-噁二唑、1,3,4-噁二唑、1,2,3-噻二唑、1,2,4-噻二唑、1,2,5-噻二唑、1,3,4-噻二唑;6員環,諸如吡啶、噠嗪、嘧啶、吡嗪、1,3,5-三嗪、1,2,4-三嗪、1,2,3-三嗪、1,2,4,5-四嗪、1,2,3,4-四嗪、1,2,3,5-四嗪;或稠合基團,諸如吲哚、異吲哚、吲哚嗪、吲唑、苯并咪唑、苯并三唑、嘌呤、萘咪唑、菲咪唑、吡啶咪唑、吡嗪咪唑、喹喏啉咪唑、苯并噁唑、萘并噁唑、蒽并噁唑、菲并噁唑、異噁唑、苯并噻唑、苯并呋喃、異苯并呋喃、二苯并呋喃、喹啉、異喹啉、喋啶、苯并-5,6-喹啉、苯并-6,7-喹啉、苯并-7,8-喹啉、苯并異喹啉、吖啶、啡噻嗪、啡噁嗪、苯并噠嗪、苯并嘧啶、喹喏啉、吩嗪、萘啶、氮雜咔唑、苯并咔啉、啡啶、啡啉、噻吩并[2,3b]噻吩、噻吩并[3,2b]噻吩、二噻吩并噻吩、異苯并噻吩、二苯并噻吩、苯并噻二唑并噻吩或該等基團之組合。雜芳基亦可經烷基、烷氧基、硫烷基、氟、氟烷基或其他芳基或雜芳基取代。Preferred heteroaryl groups are, for example, 5-membered rings such as pyrrole, pyrazole, imidazole, 1,2,3-triazole, 1,2,4-triazole, tetrazole, furan, thiophene, selenophene, oxazole, Isoxazole, 1,2-thiazole, 1,3-thiazole, 1, 2,3-oxadiazole, 1, 2, 4-oxadiazole, 1, 2, 5-oxadiazole, 1, 3, 4-oxadiazole, 1,2,3-thiadiazole, 1,2,4-thiadiazole, 1,2,5-thiadiazole, 1,3,4-thiadiazole; 6-membered ring, Such as pyridine, pyridazine, pyrimidine, pyrazine, 1,3,5-triazine, 1,2,4-triazine, 1,2,3-triazine, 1,2,4,5-tetrazine, 1 , 2,3,4-tetrazine, 1,2,3,5-tetrazine; or fused groups such as indole, isoindole, indazine, indazole, benzimidazole, benzotriazole , Purine, naphthalimidazole, fimidazole, pyrimidazole, pyrazine imidazole, quinazoline imidazole, benzoxazole, naphthoxazole, anthraxazole, phenanthrazole, isoxazole, benzothiazole, benzene Benzofuran, isobenzofuran, dibenzofuran, quinoline, isoquinoline, pyridine, benzo-5,6-quinoline, benzo-6,7-quinoline, benzo-7,8- Quinoline, benzoisoquinoline, acridine, phenothiazine, phenoxazine, benzopyrazine, benzopyrimidine, quinoxaline, phenazine, naphthyridine, azacarbazole , Benzocarboline, phenanthroline, morpholine, thieno [2,3b] thiophene, thieno [3,2b] thiophene, dithienothiophene, isobenzothiophene, dibenzothiophene, benzothiadiazole Thiophene or a combination of these groups. Heteroaryl groups can also be substituted with alkyl, alkoxy, sulfanyl, fluoro, fluoroalkyl, or other aryl or heteroaryl groups.

在本申請案之上下文中,術語「(非芳族)脂環族基」涵蓋飽和環且「雜環基」涵蓋飽和環,亦即排他性地含有單鍵之彼等,及部分不飽和環,亦即亦可含有多重鍵之彼等。雜環含有一或多個較佳地選自Si、O、N、S及Se之雜原子。(非芳族)脂環族基及雜環基可為單環,亦即僅含有一個環(諸如環己烷)或為多環,亦即含有複數個環(諸如十氫萘或二環辛烷)。此外,較佳為具有3至25個C原子之單環、二環或三環基團,其視情況含有稠環且視情況經取代。此外,較佳為5員、6員、7員或8員碳環基團,另外,其中一或多個C原子可經Si置換及/或一或多個CH基團可經N置換及/或一或多個不相鄰CH2 基團可經-O-及/或-S-置換。較佳脂環族基及雜環基為例如5員基團,諸如環戊烷、四氫呋喃、四氫硫代呋喃、吡咯啶;6員基團,諸如環己烷、環己矽烷、四氫哌喃、四氫硫代哌喃、1,3-二噁烷、1,3-二噻、哌啶;7員基團,諸如環庚烷;及稠合基團,諸如四氫化萘、十氫萘、茚滿、雙環[1.1.1]戊烷-1,3-二基、雙環[2.2.2]辛烷-1,4-二基、螺[3.3]庚烷-2,6-二基、八氫-4,7-甲橋茚滿-2,5-二基,更佳為1,4-伸環己基4,4'-二伸環己基、3,17-十六氫-環戊[a]菲,其視情況經一或多個相同或不同基團L取代。尤其較佳芳基、雜芳基、脂環族基以及雜環基為1,4-伸苯基、4,4'-伸聯苯基、1,4-伸聯三苯基、1,4-伸環己基、4,4'-二伸環己基以及3,17-十六氫-環戊[a]-菲,該等基團視情況經一或多個相同或不同基團L取代。In the context of this application, the term "(non-aromatic) cycloaliphatic group" encompasses saturated rings and "heterocyclyl" encompasses saturated rings, that is, those that exclusively contain single bonds, and partially unsaturated rings, That is, they can also contain multiple bonds. The heterocyclic ring contains one or more heteroatoms preferably selected from Si, O, N, S and Se. (Non-aromatic) cycloaliphatic and heterocyclic groups can be monocyclic, that is, contain only one ring (such as cyclohexane) or polycyclic, that is, contain multiple rings (such as decalin or bicyclooctyl alkyl). In addition, monocyclic, bicyclic or tricyclic groups having 3 to 25 C atoms are preferred, which optionally contain fused rings and are optionally substituted. In addition, it is preferably a 5-membered, 6-membered, 7-membered, or 8-membered carbocyclic group. In addition, one or more C atoms may be substituted by Si and / or one or more CH groups may be substituted by N and / Or one or more non-adjacent CH 2 groups may be replaced by -O- and / or -S-. Preferred cycloaliphatic and heterocyclic groups are, for example, 5-membered groups such as cyclopentane, tetrahydrofuran, tetrahydrothiofuran, and pyrrolidine; 6-membered groups such as cyclohexane, cyclohexylsilane, tetrahydropiperidine Pyran, tetrahydrothiopiperan, 1,3-dioxane, 1,3-dithia, piperidine; 7-membered groups such as cycloheptane; and fused groups such as tetralin, decahydro Naphthalene, Indan, Bicyclo [1.1.1] pentane-1,3-diyl, Bicyclo [2.2.2] octane-1,4-diyl, Spiro [3.3] heptane-2,6-diyl Octahydro-4,7-methyl bridge indane-2,5-diyl, more preferably 1,4-cyclohexyl 4,4'-dicyclohexyl, 3,17-hexadecane-cyclopentyl [a] phenanthrene, optionally substituted with one or more of the same or different groups L. Particularly preferred aryl, heteroaryl, cycloaliphatic and heterocyclic groups are 1,4-phenylene, 4,4'-biphenyl, 1,4-triphenyl, 1,4 -Cyclohexyl, 4,4'-dicyclohexyl, and 3,17-hexadecyl-cyclopenta [a] -phenanthrene, which are optionally substituted with one or more same or different groups L.

上文所提及之芳基、雜芳基、脂環族基及雜環基之較佳取代基(L)為例如可溶性促進基團(諸如,烷基或烷氧基)及拉電子基團(諸如,氟、硝基或腈)。Preferred substituents (L) of the aryl, heteroaryl, cycloaliphatic and heterocyclic groups mentioned above are, for example, a solubility-promoting group (such as an alkyl group or an alkoxy group) and an electron-withdrawing group (Such as fluorine, nitro or nitrile).

尤其較佳取代基為例如鹵素、CN、NO2 、CH3 、C2 H5 、OCH3 、OC2 H5 、COCH3 、COC2 H5 、COOCH3 、COOC2 H5 、CF3 、OCF3 、OCHF2 或OC2 F5Particularly preferred substituents are, for example, halogen, CN, NO 2 , CH 3 , C 2 H 5 , OCH 3 , OC 2 H 5 , COCH 3 , COC 2 H 5 , COOCH 3 , COOC 2 H 5 , CF 3 , OCF 3. OCHF 2 or OC 2 F 5 .

在上文及下文中,「鹵素」表示F、Cl、Br或I。Above and below, "halogen" means F, Cl, Br or I.

在上文及下文中,術語「烷基」、「芳基」、「雜芳基」等亦包涵例如伸烷基、伸芳基、伸雜芳基等之多價基團。In the above and below, the terms "alkyl", "aryl", "heteroaryl" and the like also encompass polyvalent groups such as alkylene, aryl, heteroaryl and the like.

術語「芳基」表示芳族碳基團或自其衍生之基團。The term "aryl" refers to an aromatic carbon group or a group derived therefrom.

術語「雜芳基」表示根據上文定義含有一或多個雜原子之「芳基」。The term "heteroaryl" refers to an "aryl" containing one or more heteroatoms as defined above.

較佳烷基為例如甲基、乙基、正丙基、異丙基、正丁基、異丁基、第二丁基、第三丁基、2-甲基丁基、正戊基、第二戊基、環戊基、正己基、環己基、2-乙基己基、正庚基、環庚基、正辛基、環辛基、正壬基、正癸基、正十一烷基、正十二烷基、十二烷基、三氟甲基、全氟正丁基、2,2,2-三氟乙基、全氟辛基、全氟己基等。Preferred alkyl groups are, for example, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, second butyl, third butyl, 2-methylbutyl, n-pentyl, Dipentyl, cyclopentyl, n-hexyl, cyclohexyl, 2-ethylhexyl, n-heptyl, cycloheptyl, n-octyl, cyclooctyl, n-nonyl, n-decyl, n-undecyl, N-dodecyl, dodecyl, trifluoromethyl, perfluoro-n-butyl, 2,2,2-trifluoroethyl, perfluorooctyl, perfluorohexyl and the like.

較佳烷氧基為例如甲氧基、乙氧基、2-甲氧基-乙氧基、正丙氧基、異丙氧基、正丁氧基、異丁氧基、第二丁氧基、第三丁氧基、2-甲基丁氧基、正戊氧基、正己氧基、正庚氧基、正辛氧基、正壬氧基、正癸氧基、正十一烷氧基、正十二烷氧基。Preferred alkoxy groups are, for example, methoxy, ethoxy, 2-methoxy-ethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, second butoxy , Third butoxy, 2-methylbutoxy, n-pentoxy, n-hexyloxy, n-heptyloxy, n-octyloxy, n-nonoxy, n-decoxy, n-undecyloxy N-dodecyloxy.

較佳烯基為例如乙烯基、丙烯基、丁烯基、戊烯基、己烯基、庚烯基及辛烯基。Preferred alkenyl groups are, for example, vinyl, propenyl, butenyl, pentenyl, hexenyl, heptenyl and octenyl.

較佳炔基為例如乙炔基、丙炔基、丁炔基、戊炔基、己炔基、辛炔基。Preferred alkynyl is, for example, ethynyl, propynyl, butynyl, pentynyl, hexynyl, octynyl.

氧雜烷基,亦即其中一個CH2 基團經-O-置換,較佳為例如直鏈2-氧雜丙基(=甲氧基甲基);2-氧雜丁基(=乙氧基甲基)或3-氧雜丁基(=2-甲氧基乙基);2-氧雜戊基、3-氧雜戊基或4-氧雜戊基;2-氧雜己基、3-氧雜己基、4-氧雜己基或5-氧雜己基;2-氧雜庚基、3-氧雜庚基、4-氧雜庚基、5-氧雜庚基或6-氧雜庚基;2-氧雜辛基、3-氧雜辛基、4-氧雜辛基、5-氧雜辛基、6-氧雜辛基 或7-氧雜辛基;2-氧雜壬基、3-氧雜壬基、4-氧雜壬基、5-氧雜壬基、6-氧雜壬基、7-氧雜壬基或8-氧雜壬基或2-氧雜癸基、3-氧雜癸基、4-氧雜癸基、5-氧雜癸基、6-氧雜癸基、7-氧雜癸基、8-氧雜癸基或9-氧雜癸基。An oxaalkyl group, that is, one of the CH 2 groups is replaced by -O-, and is preferably, for example, a linear 2-oxopropyl group (= methoxymethyl); a 2-oxobutyl group (= ethoxy group) Methyl) or 3-oxobutyl (= 2-methoxyethyl); 2-oxopentyl, 3-oxopentyl or 4-oxopentyl; 2-oxexyl, 3 -Oxahexyl, 4-oxahexyl or 5-oxahexyl; 2-oxaheptyl, 3-oxaheptyl, 4-oxaheptyl, 5-oxaheptyl or 6-oxaheptyl Base; 2-oxaoctyl, 3-oxaoctyl, 4-oxaoctyl, 5-oxaoctyl, 6-oxaoctyl or 7-oxaoctyl; 2-oxanonyl , 3-oxanonyl, 4-oxanonyl, 5-oxanonyl, 6-oxanonyl, 7-oxanonyl or 8-oxanonyl or 2-oxadecyl, 3-oxadecyl, 4-oxadecyl, 5-oxadecyl, 6-oxadecyl, 7-oxadecyl, 8-oxadecyl or 9-oxadecyl.

較佳胺基為例如二甲胺基、甲胺基、甲基苯胺基、苯胺基。Preferred amine groups are, for example, dimethylamino, methylamino, methylaniline, and aniline.

術語「對掌性」一般用於描述與其鏡像不能重疊之物體。The term "palace" is generally used to describe an object that cannot overlap its mirror image.

「非對掌性(achiral/non-chiral)」物體為與其鏡像相同之物體。An "achiral / non-chiral" object is the same as its mirror image.

除非另外明確陳述,否則在本申請案中,術語「對掌性向列型」與「膽固醇型」同義地使用。Unless explicitly stated otherwise, in this application, the term "palate nematic" is used synonymously with "cholesterol."

術語「雙液晶原化合物」係指分子中包含兩個液晶原基團之化合物。正如正常液晶原基,視其結構而定,其可形成許多中間相。特定言之,當被添加至向列型液晶介質中時,雙液晶原化合物可誘導第二向列相。雙液晶原化合物亦被稱為「二聚液晶」。The term "dual mesogen" refers to a compound that contains two mesogen groups in the molecule. Just like the normal mesogen, depending on its structure, it can form many mesophases. In particular, when added to a nematic liquid crystal medium, a dual mesogen compound can induce a second nematic phase. Dual mesogen compounds are also called "dimeric liquid crystals".

術語「引向器」在先前技術中已知且意謂液晶分子之長分子軸(在棒狀化合物之情況下)或短分子軸(在盤狀化合物之情況下)之較佳定向方向。在此等各向異性分子單軸排序之情況下,引向器為各向異性之軸。The term "director" is known in the prior art and means a preferred orientation direction of the long molecular axis (in the case of rod-like compounds) or the short molecular axis (in the case of disc-shaped compounds) of liquid crystal molecules. In the case of uniaxial ordering of these anisotropic molecules, the director is the anisotropic axis.

術語「配向」或「定向」係關於材料之各向異性單元之配向(定向排序),諸如小分子或大分子碎片在稱為「配向方向」之共同方向。在液晶材料之配向層中,液晶引向器與配向方向一致以使得配向方向對應於材料之各向異性軸之方向。The term "alignment" or "orientation" refers to the alignment (orientation ordering) of anisotropic units of a material, such as small molecules or macromolecular fragments in a common direction called "alignment direction". In the alignment layer of the liquid crystal material, the liquid crystal director is aligned with the alignment direction so that the alignment direction corresponds to the direction of the anisotropic axis of the material.

術語「平面定向/配向」,例如在液晶材料之層中意謂一定比例之液晶分子的長分子軸(在棒狀化合物之情況下)或短分子軸(在盤狀化合物之情況下)與該層之平面基本上平行(約180°)地定向。The term "planar orientation / alignment" means, for example, in a layer of liquid crystal material, a long molecular axis (in the case of a rod-like compound) or a short molecular axis (in the case of a discotic compound) of a certain proportion of liquid crystal molecules and the layer The planes are oriented substantially parallel (about 180 °).

術語「垂直定向/配向」,例如在液晶材料之層中意謂一定比例之液晶分子的長分子軸(在棒狀化合物之情況下)或短分子軸(在盤狀化合物之情況下)相對於該層之平面以約80°至90°之間的角度θ (「傾斜角」)定向。The term "vertical orientation / alignment" means, for example, in the layer of a liquid crystal material, a long molecular axis (in the case of a rod-like compound) or a short molecular axis (in the case of a discotic compound) of a certain proportion of liquid crystal molecules relative to The plane of the layers is oriented at an angle θ ("tilt angle") between about 80 ° and 90 °.

液晶材料之術語「均一定向」或「均一配向」,例如在材料之層中意謂液晶分子之長分子軸(在棒狀化合物之情況下)或短分子軸(在盤狀化合物之情況下)基本上在相同方向上定向。換言之,液晶引向器之線平行。The term "uniform orientation" or "uniform alignment" of liquid crystal materials, for example, means that the long molecular axis (in the case of rod-like compounds) or the short molecular axis (in the case of discoid compounds) of liquid crystal molecules in the layer of the material are basically Up in the same direction. In other words, the lines of the liquid crystal director are parallel.

除非另外明確指定,否則在本申請案中通常指代之光波長為550 nm。Unless specifically stated otherwise, the wavelength of light generally referred to in this application is 550 nm.

在本文中雙折射率Δn由以下等式定義
Dn = ne - no
其中ne 係異常折射率且no 係普通折射率,且有效平均折射率nav. 由以下等式給出:
nav. = [(2 no 2 + ne 2 )/3]1/2
The birefringence Δn is defined by the following equation
Dn = n e -n o
Where n e is the abnormal refractive index and n o is the ordinary refractive index, and the effective average refractive index n av. Is given by the following equation:
n av. = [(2 n o 2 + n e 2 ) / 3] 1/2

可使用阿貝(Abbe)折射計量測異常折射率ne 及普通折射率noRefractile metering extraordinary refractive index n e measured ordinary refractive index n o and an Abbe (Abbe).

在本申請案中,術語「介電正性」係用於Δε > 3.0之化合物或組分,「介電中性」用於-1.5 ≤ Δε ≤ 3.0之化合物或組分及「介電負性」用於Δε < -1.5之化合物或組分。在1 kHz之頻率下且在20℃下測定Δε。各別化合物之介電各向異性由各別單一化合物於向列型主體混合物中之10%溶液之結果判定。若各別化合物在主體介質中之溶解度小於10%,則將其濃度減小2倍,直至所得介質足夠穩定以至少允許判定其特性。然而,為了保持結果之顯著性儘可能地高,較佳地使濃度保持為至少5%。測試混合物之電容係在具有垂面及沿面配向之單元中測定。兩種類型之單元的單元間隙均為大約20 µm。施加之電壓係頻率為1 kHz及均方根值通常為0.5 V至1.0 V之矩形波;然而,總是將其選擇為低於各別測試混合物之電容臨限值。In this application, the term "dielectric positive" is used for compounds or components with Δε> 3.0, "dielectric neutral" is used for compounds or components with -1.5 ≤ Δε ≤ 3.0 and "dielectric negative" "For compounds or components with Δε <-1.5. Δε was measured at a frequency of 1 kHz and at 20 ° C. The dielectric anisotropy of each compound is determined from the result of a 10% solution of each single compound in a nematic host mixture. If the solubility of each compound in the host medium is less than 10%, reduce its concentration by a factor of two until the resulting medium is sufficiently stable to allow at least its properties to be determined. However, in order to keep the significance of the results as high as possible, it is preferable to keep the concentration at least 5%. The capacitance of the test mixture is measured in cells with vertical and creeping orientations. The cell gap for both types of cells is approximately 20 µm. The applied voltage is a rectangular wave with a frequency of 1 kHz and a root mean square value of usually 0.5 V to 1.0 V; however, it is always chosen to be below the capacitance threshold of the respective test mixture.

Δε定義為(e½½ - e^ ),而εav. 為(e½½ + 2 e^ ) / 3。由在添加相關化合物之後主體介質之各別值的變化來確定化合物之介電電容率。將該等值外推至100%相關化合物濃度。典型的主體介質為皆可購自Merck, Darmstadt之ZLI-4792或BL-087。Δε is defined as (e ½½ -e ^ ), and ε av. Is (e ½½ + 2 e ^ ) / 3. The dielectric permittivity of a compound is determined by changes in the respective values of the host medium after the relevant compound is added. Extrapolate these values to 100% related compound concentrations. Typical host media are ZLI-4792 or BL-087, both available from Merck, Darmstadt.

對於本發明,

表示反-1,4-伸環己基,

表示1,4-伸苯基。
For the present invention,

For trans-1,4-cyclohexyl,

Represents 1,4-phenylene.

對於本發明,基團-COO- -C(=O)O-或-CO2 -表示具有式之酯基團,且基團-OCO-、-OC(=O)-、-O2 C-或-OOC-表示具有式之酯基團。For the present invention, the group -COO- -C (= O) O- or -CO 2 -represents having the formula An ester group, and the groups -OCO-, -OC (= O)-, -O 2 C-, or -OOC- represent a formula Of an ester group.

此外,如C. Tschierske, G. Pelzl及S. Diele, Angew. Chem. 2004, 116, 6340-6368中給出之定義將適用於本申請案中之關於液晶材料之未定義術語。In addition, the definitions given in C. Tschierske, G. Pelzl and S. Diele, Angew. Chem. 2004, 116, 6340-6368 will apply to the undefined terms regarding liquid crystal materials in this application.

在具有非極性基團之化合物之情況下,R12 較佳為烷基、烷氧基、烯基或炔基,較佳烷基、烷氧基,其具有至多15個C原子、較佳2至10個C原子、更佳2至5個C原子。In the case of a compound having a non-polar group, R 12 is preferably an alkyl group, an alkoxy group, an alkenyl group or an alkynyl group, preferably an alkyl group or an alkoxy group, which has at most 15 C atoms, preferably 2 Up to 10 C atoms, more preferably 2 to 5 C atoms.

此外,含有非對掌性分支鏈基團R12 之式I之化合物可偶爾具有重要性,例如歸因於朝向結晶之傾向減小。此類型之分支鏈基團通常不含多於一個的鏈分支。較佳非對掌性分支鏈基團為異丙基、異丁基(=甲基丙基)、異戊基(=3-甲基丁基)、異丙氧基、2-甲基-丙氧基及3-甲基丁氧基。Furthermore, compounds of formula I containing a non-palladium branched group R 12 may occasionally be of importance, for example due to a reduced tendency towards crystallization. This type of branched chain group usually does not contain more than one chain branch. Preferred non-palladium branched groups are isopropyl, isobutyl (= methylpropyl), isoamyl (= 3-methylbutyl), isopropyloxy, 2-methyl-propyl And 3-methylbutoxy.

在具有末端極性基團之化合物的情況下,R12 係選自CN、NO2 、NCS、NCO、鹵素、OCH3 、OCN、SCN、CORx 、COORx 或具有1至4個C原子之單氟化、寡氟化或多氟化烷基或烷氧基。Rx 為具有1至4個、較佳1至3個C原子之視情況氟化的烷基。鹵素較佳為F或Cl。In the case of a compound having a terminal polar group, R 12 is selected from CN, NO 2 , NCS, NCO, halogen, OCH 3 , OCN, SCN, COR x , COOR x or a single having 1 to 4 C atoms Fluorinated, oligofluorinated or polyfluorinated alkyl or alkoxy. R x is an optionally fluorinated alkyl group having 1 to 4, preferably 1 to 3 C atoms. The halogen is preferably F or Cl.

式I中尤其較佳的R12 經選定為NO2 、NCS或NCO。Particularly preferred R 12 in formula I is selected as NO 2 , NCS or NCO.

更佳地R11 與R12 相同且表示NO2 、NCS或NCO。More preferably R 11 is the same as R 12 and represents NO 2 , NCS or NCO.

尤其較佳為子式,其中Z在各種情況下獨立地具有如式I下給出的Z11 之含義中之一者,且若存在兩個則較佳Z中之一個為-COO-、-OCO-、-CF2 -O-或-O-CF2 -。Especially preferred is a sub-formula, in which Z independently has one of the meanings of Z 11 given in Formula I in each case, and if there are two, one of Z is preferably -COO-,- OCO-, -CF 2 -O- or -O-CF 2- .

僅包含6元環之較佳基團-A11 (-Z11 -A12 -)p -或-(A13 -Z12 -)q A14 -的較小基團列於以下。為簡單起見,該等基團中Phe為1,4-伸苯基,PheL為經1至4個基團L取代之1,4-伸苯基,其中L較佳為F、Cl、CN、OH、NO2 或視情況氟化之具有1至7個C原子之烷基、烷氧基或烷醯基,極佳為F、Cl、CN、OH、NO2 、CH3 、C2 H5 、OCH3 、OC2 H5 、COCH3 、COC2 H5 、COOCH3 、COOC2 H5 、CF3 、OCF3 、OCHF2 、OC2 F5 ,尤其為F、Cl、CN、CH3 、C2 H5 、OCH3 、COCH3 及OCF3 ,最佳為F、Cl、CH3 、OCH3 及COCH3 ,且CHex為1,4-伸環己基。此清單包含以下展示之子式,
其中
CHex 為1,4-伸環己基,較佳為反-1,4-伸環己基,
Phe 為1,4-伸苯基,
PheL 為1,4-伸苯基,其經一個、兩個或三個氟原子、經一個或兩個Cl原子或經一個Cl原子及一個F原子取代,且
Z 具有如在部分式II下給出的Z11 之含義中之一者,且若存在兩個則較佳至少一個選自-COO-、-OCO-、-OCH2 -、-CH2 O-、-OCF2 -或-CF2 O-。
Preferred groups containing only a 6-membered ring -A 11 (-Z 11 -A 12- ) p -or-(A 13 -Z 12- ) q A 14 -are listed below. For simplicity, Phe in these groups is 1,4-phenylene, and PheL is 1,4-phenylene substituted with 1 to 4 groups L, where L is preferably F, Cl, CN , OH, NO 2 or optionally fluorinated alkyl, alkoxy or alkanoyl groups having 1 to 7 C atoms, preferably F, Cl, CN, OH, NO 2 , CH 3 , C 2 H 5 , OCH 3 , OC 2 H 5 , COCH 3 , COC 2 H 5 , COOCH 3 , COOC 2 H 5 , CF 3 , OCF 3 , OCHF 2 , OC 2 F 5 , especially F, Cl, CN, CH 3 , C 2 H 5 , OCH 3 , COCH 3 and OCF 3 , most preferably F, Cl, CH 3 , OCH 3 and COCH 3 , and CHex is 1,4-cyclohexyl. This list contains the subforms shown below,
among them
CHex is 1,4-cyclohexyl, preferably trans-1,4-cyclohexyl,
Phe is 1,4-phenylene,
PheL is 1,4-phenylene, which is substituted by one, two or three fluorine atoms, by one or two Cl atoms, or by a Cl atom and an F atom, and
Z has one of the meanings of Z 11 as given under Partial Formula II, and if two are present, preferably at least one is selected from -COO-, -OCO-, -OCH 2- , -CH 2 O- , -OCF 2 -or -CF 2 O-.

尤其較佳為子式,其中Z在各種情況下獨立地具有如式I下給出的Z11 之含義中之一者,且若存在兩個則較佳Z中之一個為-COO-或-OCO-。Especially preferred is the sub-formula, in which Z independently has one of the meanings of Z 11 given in Formula I in each case, and if there are two, it is preferred that one of Z is -COO- or- OCO-.

在以上給出之較佳子式中,PheL較佳表示基團In the preferred formulae given above, PheL preferably represents a group .

其中L較佳為F、Cl、CH3 、OCH3 及COCH3 Among them, L is preferably F, Cl, CH 3 , OCH 3 and COCH 3 .

尤其較佳為式I之化合物,其中液晶原基團-A11 (-Z11 -A12 -)p -或-(A13 -Z12 -)q A14 -之各別對各自包含兩個或三個六原子環,更佳地-A11 (-Z11 -A12 -)p -或-(A13 -Z12 -)q A14 -各自包含兩個六原子環或-A11 (-Z11 -A12 -)p -包含兩個六原子環且-(A13 -Z12 -)q A14 包含三個六原子環或-A11 (-Z11 -A12 -)p -包含三個六原子環及/或-(A13 -Z12 -)q A14 -包含兩個六原子環。Particularly preferred are compounds of formula I, wherein the respective pairs of mesogen groups -A 11 (-Z 11 -A 12- ) p -or-(A 13 -Z 12- ) q A 14 -each contain two Or three six-atom rings, more preferably -A 11 (-Z 11 -A 12- ) p -or-(A 13 -Z 12- ) q A 14 -each containing two six-atom rings or -A 11 ( -Z 11 -A 12- ) p -contains two six-atom rings and-(A 13 -Z 12- ) q A 14 contains three six-atom rings or -A 11 (-Z 11 -A 12- ) p- Contains three six-atom rings and / or-(A 13 -Z 12- ) q A 14 -includes two six-atom rings.

在一較佳實施例中,-A11 (-Z11 -A12 -)p -或-(A13 -Z12 -)q A14 -按液晶原基團皆為彼此之鏡像選擇,例如若-A11 (-Z11 -A12 -)p -表示-Phe-PheL-則-(A13 -Z12 -)q A14 表示-PheL-Phe-。In a preferred embodiment, -A 11 (-Z 11 -A 12- ) p -or-(A 13 -Z 12- ) q A 14 -are selected as mirror images of each other according to the original mesogen groups, for example, if -A 11 (-Z 11 -A 12- ) p -represents -Phe-PheL-then-(A 13 -Z 12- ) q A 14 represents -PheL-Phe-.

更佳為式I之化合物,其中
Sp11 表示-(CH2 )n -,其中
n 1至15之整數,其中一或多個-CH2 -基團可經-CO-置換,較佳為非偶數整數,更佳為3、5、7、9、11或13,
More preferred are compounds of formula I, wherein
Sp 11 represents-(CH 2 ) n- , where
n is an integer from 1 to 15, wherein one or more -CH 2 -groups may be replaced by -CO-, preferably a non-even integer, more preferably 3, 5, 7, 9, 11, or 13,

更佳式I之化合物為彼等化合物,其中
-X11 -Sp11 -X12 - 為-Sp11 -、-Sp11 -O-、-Sp11 -CO-O-、-Sp11 -O-CO-、-Sp11 -CF2 O-、-CO-O-Sp11 、-O-CO-Sp11 、-O-Sp11 -、-OCF2 -Sp11 -、-O-Sp11 -O-、-OCF2 -Sp11 -CF2 O-、-O-Sp11 -CO-O-、-O-Sp11 -O-CO-、-O-CO-Sp11 -O-、-O-CO-Sp11 -O-CO-、-CO-O-Sp11 -O-或-CO-O-Sp11 -CO-O-,然而限制條件為在-X11 -Sp11 -X12 -中沒有兩個O原子彼此相鄰,沒有兩個-CH=CH-基團彼此相鄰且沒有兩個選自-O-CO-、-S-CO-、-O-COO-、-CO-S-、-CO-O-及-CH=CH-之基團彼此相鄰。
More preferred compounds of formula I are their compounds, wherein
-X 11 -Sp 11 -X 12 - is -Sp 11 -, - Sp 11 -O -, - Sp 11 -CO-O -, - Sp 11 -O-CO -, - Sp 11 -CF 2 O-, -CO-O-Sp 11 , -O-CO-Sp 11 , -O-Sp 11- , -OCF 2 -Sp 11- , -O-Sp 11 -O-, -OCF 2 -Sp 11 -CF 2 O -, -O-Sp 11 -CO-O-, -O-Sp 11 -O-CO-, -O-CO-Sp 11 -O-, -O-CO-Sp 11 -O-CO-, -CO -O-Sp 11 -O- or -CO-O-Sp 11 -CO-O-, however the restriction is that no two O atoms are adjacent to each other and no two in -X 11 -Sp 11 -X 12- -CH = CH- groups are adjacent to each other and no two are selected from -O-CO-, -S-CO-, -O-COO-, -CO-S-, -CO-O-, and -CH = CH -Groups are adjacent to each other.

更佳式I之化合物為彼等化合物,其中-X11 -Sp11 -X12 - 表示-Sp11 -、-O-Sp11 -O-、-OCF2 -Sp11 -CF2 O-或-O-CO-Sp11 -O-CO-,More preferred compounds of formula I are their compounds, wherein -X 11 -Sp 11 -X 12 -represents -Sp 11- , -O-Sp 11 -O-, -OCF 2 -Sp 11 -CF 2 O- or- O-CO-Sp 11 -O-CO-,

更佳式I之化合物選自以下子結構,




其中
L 在每次出現時各自且獨立地表示F、Cl、CH3 、OCH3 及COCH3 ,較佳F,
r 表示在0與4之間的整數,較佳0、1或2,
n 表示3、5、7、9、11或13。
More preferably the compound of formula I is selected from the following substructures,




among them
Each occurrence of L represents F, Cl, CH 3 , OCH 3 and COCH 3 respectively , preferably F,
r represents an integer between 0 and 4, preferably 0, 1, or 2,
n represents 3, 5, 7, 9, 11, or 13.

更佳式I之化合物選自以下子結構,




其中
L 在每次出現時各自且獨立地表示F、Cl、CH3 、OCH3 及COCH3 ,較佳F,
n 表示3、5、7、9、11或13,較佳7、9或11。
More preferably the compound of formula I is selected from the following substructures,




among them
Each occurrence of L represents F, Cl, CH 3 , OCH 3 and COCH 3 respectively , preferably F,
n represents 3, 5, 7, 9, 11, or 13, preferably 7, 9, or 11.

尤其較佳的式I之化合物選自子結構I-1-1至I-1-3、I-3-1至I-3-3、I-5-1至I-5-3及I-7-1至I-7-3,較佳選自I-1-1、I-1-3、I-3-1、I-3-3、I-5-1、I-5-3、I-7-1及I-7-3,更佳選自I-1-3、I-3-3、I-5-3及I-7-3,其中L表示F且n表示7、9或11。Particularly preferred compounds of formula I are selected from the substructures I-1-1 to I-1-3, I-3-1 to I-3-3, I-5-1 to I-5-3 and I- 7-1 to I-7-3, preferably selected from I-1-1, I-1-3, I-3-1, I-3-3, I-5-1, I-5-3, I-7-1 and I-7-3, more preferably selected from I-1-3, I-3-3, I-5-3, and I-7-3, where L represents F and n represents 7, 9 Or 11.

可根據或以類似於本身已知及描述於有機化學之標準著作(例如Houben-Weyl, Methoden der organischen Chemie, Thieme-Verlag, Stuttgart)中之方法來合成式I之化合物。Compounds of formula I can be synthesized according to or in a manner similar to standard works known per se and described in organic chemistry (for example, Houben-Weyl, Methoden der organischen Chemie, Thieme-Verlag, Stuttgart).

舉例而言,在用於撓曲電應用之LC介質中使用式I之化合物之主要優勢之一係提高ULH (均勻橫向螺旋)幾何形狀之切換速度,特別在低於35℃之溫度下。亦觀測到在相範圍方面、在增加的各向同性至向列型澄清點之方面以及在低於室溫下降低的向列型至向列型扭曲彎曲轉變溫度方面之優勢。For example, one of the main advantages of using compounds of Formula I in LC dielectrics for flexure applications is to increase the switching speed of the ULH (Uniform Transverse Helix) geometry, especially at temperatures below 35 ° C. Advantages have also been observed in phase range, in terms of increased isotropic to nematic clarification points, and in reduced nematic to nematic torsional bending transition temperatures below room temperature.

因此,本發明亦關於式I之化合物在LC介質中之用途且由此關於包含一或多種式I之化合物之LC介質。The invention therefore also relates to the use of compounds of formula I in LC media and thus to LC media comprising one or more compounds of formula I.

在一較佳實施例中,根據本發明之LC介質包含一或多種式II之化合物,
R21 -A21 -A22 -(CH2 )a -A23 -A24 -R22 II
其中
R21 及R22 獨立地表示H、F、Cl、CN或直鏈或分支鏈烷基,該直鏈或分支鏈烷基可為未經取代、經鹵素或CN單取代或多取代的,一或多個不相鄰CH2 基團亦可能在每次出現時彼此獨立地經以下基團置換:-O-、-S-、-NH-、-N(CH3 )-、-CO-、-COO-、-OCO-、-O-CO-O-、-S-CO-、-CO-S-、-CH=CH-、-CH=CF-、-CF=CF-或-C≡C-,置換方式為使得氧原子彼此不直接連接,
較佳為F、Cl、CN、可未經取代、經鹵素或CN單取代或多取代之直鏈或分支鏈烷基或烷氧基,
更佳為F、CN或OCF3
A21 至A24 在每次出現時獨立地表示芳基、雜芳基、脂環族基及雜環基,
較佳為1,4-伸苯基,另外其中一或多個CH基團可經N置換;1,4-二環-(2,2,2)-伸辛基;萘-2,6-二基;十氫萘-2,6-二基;1,2,3,4-四氫-萘-2,6-二基;環丁烷-1,3-二基;螺[3.3]庚烷-2,6-二基或二螺[3.1.3.1]癸烷-2,8-二基,所有該等基團可能為未經取代、經F、Cl、CN或烷基、烷氧基、烷基羰基或烷氧羰基單取代、二取代、三取代或四取代的,其中一或多個H原子可經F或Cl取代,
更佳在每次出現時各自獨立地為,1,4-伸苯基,另外其中一或多個CH基團可經N置換;或反-1,4-伸環己基,另外其中一個或兩個不相鄰CH2 基團可經O及/或S置換,兩種環基團皆可能為未經取代、經F、Cl、CN或烷基、烷氧基、烷基羰基或烷氧羰基單取代、二取代、三取代或四取代的,其中一或多個H原子可經F或Cl取代,
a 表示1至15之整數,較佳奇數(亦即非偶數)整數,且更佳3、5、7、9或11。
In a preferred embodiment, the LC medium according to the present invention comprises one or more compounds of formula II,
R 21 -A 21 -A 22- (CH 2 ) a -A 23 -A 24 -R 22 II
among them
R 21 and R 22 independently represent H, F, Cl, CN or a linear or branched alkyl group, and the linear or branched alkyl group may be unsubstituted, mono- or poly-substituted with halogen or CN, a Or, multiple non-adjacent CH 2 groups may also be replaced independently of each other by the following groups at each occurrence: -O-, -S-, -NH-, -N (CH 3 )-, -CO-, -COO-, -OCO-, -O-CO-O-, -S-CO-, -CO-S-, -CH = CH-, -CH = CF-, -CF = CF- or -C≡C -, The substitution method is such that the oxygen atoms are not directly connected to each other,
Preferred are F, Cl, CN, straight or branched chain alkyl or alkoxy which may be unsubstituted, mono- or poly-substituted with halogen or CN,
More preferably F, CN or OCF 3 ,
A 21 to A 24 each independently represent an aryl group, a heteroaryl group, an alicyclic group, and a heterocyclic group,
1,4-phenylene is preferred, and one or more CH groups may be replaced by N; 1,4-bicyclo- (2,2,2) -octyl; naphthalene-2,6- Diyl; decalin-2,6-diyl; 1,2,3,4-tetrahydro-naphthalene-2,6-diyl; cyclobutane-1,3-diyl; spiro [3.3] heptane Alkan-2,6-diyl or bisspiro [3.1.3.1] decane-2,8-diyl, all such groups may be unsubstituted, via F, Cl, CN or alkyl, alkoxy , Alkylcarbonyl or alkoxycarbonyl mono-, di-, tri- or tetra-substituted in which one or more H atoms may be substituted by F or Cl,
More preferably, each occurrence is independently 1,4-phenylene, and one or more of the CH groups may be replaced by N; or trans-1,4-cyclohexyl, and one or two of them Non-adjacent CH 2 groups can be replaced by O and / or S, both ring groups may be unsubstituted, F, Cl, CN or alkyl, alkoxy, alkylcarbonyl or alkoxycarbonyl Mono-, di-, tri- or tetra-substituted, in which one or more H atoms may be substituted by F or Cl,
a represents an integer from 1 to 15, preferably an odd (ie, non-even) integer, and more preferably 3, 5, 7, 9, or 11.

較佳的式II之化合物係選自其中基團(-A21 -A22 -)及(-A23 -A24 -)各自且獨立地選自以下基團之化合物
-Phe-Phe- MG1
-PheL-PheL- MG2
-Phe-PheL- MG3
-PheL-Phe- MG4
其中,
Phe 在該等基團中為1,4-伸苯基,
PheL 為經1至4個基團L取代之1,4-伸苯基,其中L較佳為F、Cl、CN、OH、NO2 或視情況氟化之具有1至7個C原子之烷基、烷氧基或烷醯基,極佳為F、Cl、CN、OH、NO2 、CH3 、C2 H5 、OCH3 、OC2 H5 、COCH3 、COC2 H5 、COOCH3 、COOC2 H5 、CF3 、OCF3 、OCHF2 、OC2 F5 ,尤其為F、Cl、CN、CH3 、C2 H5 、OCH3 、COCH3 及OCF3 ,最佳為F、Cl、CH3 、OCH3 及COCH3
Cyc 為1,4-伸環己基。
Preferred compounds of formula II are selected from compounds wherein the groups (-A 21 -A 22- ) and (-A 23 -A 24- ) are each and independently selected from the following groups
-Phe-Phe- MG1
-PheL-PheL- MG2
-Phe-PheL- MG3
-PheL-Phe- MG4
among them,
Phe is 1,4-phenylene in these groups,
PheL is 1,4-phenylene substituted by 1 to 4 groups L, where L is preferably F, Cl, CN, OH, NO 2 or optionally fluorinated alkane having 1 to 7 C atoms Group, alkoxy or alkylfluorenyl, preferably F, Cl, CN, OH, NO 2 , CH 3 , C 2 H 5 , OCH 3 , OC 2 H 5 , COCH 3 , COC 2 H 5 , COOCH 3 , COOC 2 H 5 , CF 3 , OCF 3 , OCHF 2 , OC 2 F 5 , especially F, Cl, CN, CH 3 , C 2 H 5 , OCH 3 , COCH 3 and OCF 3 , most preferably F, Cl, CH 3 , OCH 3 and COCH 3 and
Cyc is 1,4-cyclohexyl.

較佳為式II之化合物,其中式II中之基團(R21 -A21 -A22 -)與(-A23 -A24 -R22 )相同或為鏡像。Preferred is a compound of formula II, wherein the group (R 21 -A 21 -A 22- ) in formula II is the same as (-A 23 -A 24 -R 22 ) or is a mirror image.

同樣較佳為式II之化合物,其中式II中之(R21 -A21 -A22 -)與(-A23 -A24 -R22 )不同。Also preferred are compounds of formula II, wherein (R 21 -A 21 -A 22- ) in formula II is different from (-A 23 -A 24 -R 22 ).

較佳的式II之化合物如下所示:

Preferred compounds of formula II are shown below:

其中
n 表示1至15之整數,較佳奇數(亦即非偶數)整數,且更佳3、5、7、9或11。
among them
n represents an integer from 1 to 15, preferably an odd (ie, non-even) integer, and more preferably 3, 5, 7, 9, or 11.

可根據或以類似於本身已知及描述於有機化學之標準著作(例如Houben-Weyl, Methoden der organischen Chemie, Thieme-Verlag, Stuttgart)中之方法來合成式II之化合物。較佳製備方法可獲自WO 2013/004333 A1。Compounds of formula II can be synthesized according to or in a manner similar to standard writings known per se and described in organic chemistry (for example, Houben-Weyl, Methoden der organischen Chemie, Thieme-Verlag, Stuttgart). A preferred method of preparation is available from WO 2013/004333 A1.

為進一步提高切換速度同時保持優良相範圍及有利e/K值,在根據本發明之混合物中除式I之化合物之外還採用式II之化合物尤其有用。In order to further increase the switching speed while maintaining an excellent phase range and favorable e / K values, it is particularly useful to employ a compound of formula II in addition to the compound of formula I in the mixture according to the invention.

在一較佳實施例中,根據本發明之LC介質包含一或多種式III之化合物,
R31 -A31 -A32 -(A33 )b -Z31 -(CH2 )c -Z32 -A34 -A35 -A36 -R32 III
其中
R31 及R32 各自且彼此獨立地具有如在式II下針對R21 及R22 給出之含義中之一者,
A31 至A36 各自且彼此獨立地具有如在式II下針對A21 至A24 給出之含義中之一者,
Z31 及Z32 在每次出現時各自獨立地為-COO-、-OCO-、-O-CO-O-、-CF2 -O-、-O-CF2 -、-OCH2 -、-CH2 O-、-CH2 CH2 -、-(CH2 )4 -、-CF2 CF2 -、-CH=CH-、-CF=CF-、-CH=CH-COO-、-OCO-CH=CH-或-C≡C-,該等基團視情況經一或多個F取代,
較佳為-COO-、-OCO-或-O-CO-O-,
更佳為-COO-或-OCO-,
c 表示1至15之整數,較佳奇數(亦即非偶數)整數,且更佳3、5、7或9,且
b 表示0或1,較佳0。
In a preferred embodiment, the LC medium according to the present invention comprises one or more compounds of formula III,
R 31 -A 31 -A 32- (A 33 ) b -Z 31- (CH 2 ) c -Z 32 -A 34 -A 35 -A 36 -R 32 III
among them
R 31 and R 32 each have, independently of one another, one of the meanings given for R 21 and R 22 under Formula II,
A 31 to A 36 each and independently of one another have the meaning given for A 21 to A 24 under Formula II,
Z 31 and Z 32 are each independently -COO-, -OCO-, -O-CO-O-, -CF 2 -O-, -O-CF 2- , -OCH 2 -,- CH 2 O-, -CH 2 CH 2 -,-(CH 2 ) 4- , -CF 2 CF 2- , -CH = CH-, -CF = CF-, -CH = CH-COO-, -OCO- CH = CH- or -C≡C-, these groups are optionally substituted by one or more F,
Preferably -COO-, -OCO- or -O-CO-O-,
More preferably -COO- or -OCO-,
c represents an integer from 1 to 15, preferably an odd (i.e. non-even) integer, and more preferably 3, 5, 7, or 9, and
b represents 0 or 1, preferably 0.

較佳的式III之化合物係選自其中c表示0且基團(-A31 -A32 -)選自如上文給出的基團MG1至MG4之化合物。Preferred compounds of formula III are selected from compounds in which c represents 0 and the group (-A 31 -A 32- ) is selected from the groups MG1 to MG4 as given above.

更佳的式III之化合物係選自其中c表示1且基團(-A24 -A25 -A26 -)及(-A21 -A22 -A23 -)各自且獨立地選自以下基團的化合物
-Phe-Phe-Phe- MG5
-Phe-Phe-PheL- MG6
-Phe-PheL-Phe- MG7
-PheL-Phe-Phe- MG8
-PheL-Phe-PheL- MG9
-PheL-PheL-Phe- MG10
-PheL-PheL-PheL- MG11
其中
Phe、PheL及L具有上文針對基團MG-1至MG-4給出之含義中之一者。
More preferred compounds of formula III are selected from the group in which c represents 1 and the groups (-A 24 -A 25 -A 26- ) and (-A 21 -A 22 -A 23- ) are each independently selected from the following groups: Compound
-Phe-Phe-Phe- MG5
-Phe-Phe-PheL- MG6
-Phe-PheL-Phe- MG7
-PheL-Phe-Phe- MG8
-PheL-Phe-PheL- MG9
-PheL-PheL-Phe- MG10
-PheL-PheL-PheL- MG11
among them
Phe, PheL and L have one of the meanings given above for the groups MG-1 to MG-4.

更佳的式III之化合物係選自其中c表示0且基團(-A21 -A22 -)選自如上文給出的基團MG1至MG4且其中基團(-A24 -A25 -A26 -)選自基團MG5至MG11的化合物。More preferred compounds of formula III are selected from the group wherein c represents 0 and the group (-A 21 -A 22- ) is selected from the groups MG1 to MG4 as given above and wherein the group (-A 24 -A 25- A 26- ) A compound selected from the groups MG5 to MG11.

尤其較佳的式III之化合物係選自下式之化合物之群:

Particularly preferred compounds of formula III are selected from the group of compounds of the formula:

可根據或以類似於本身已知及描述於有機化學之標準著作(例如Houben-Weyl, Methoden der organischen Chemie, Thieme-Verlag, Stuttgart)中之方法來合成式III之化合物。Compounds of formula III can be synthesized according to or in a manner similar to standard writings known per se and described in organic chemistry (for example, Houben-Weyl, Methoden der organischen Chemie, Thieme-Verlag, Stuttgart).

為實現較高穩定性、有利的較高澄清點及寬的相範圍以及向列型扭曲-彎曲相之較低呈現,在根據本發明之混合物中除式I之化合物之外還採用式III之化合物尤其有用。In order to achieve a higher stability, a favorable higher clarification point and a wider phase range, and a lower presentation of the nematic twist-bent phase, the compounds according to the invention are also used in addition to the compounds of the formula III in the mixtures according to the invention. Compounds are particularly useful.

在一更佳實施例中,根據本發明之LC介質包含一或多種式IV之化合物,
R41 -A41 -A42 -Z41 -(CH2 )d -Z42 -A43 -A44 -R42 IV
其中
R41 及R42 各自且獨立地具有如上文在式II下針對R21 給出之含義中之一者,
A41 至A44 各自且彼此獨立地具有如上文在式II下針對A21 給出之含義中之一者,
Z41 及Z42 在每次出現時各自獨立地為-COO-、-OCO-、-O-CO-O-、-OCH2 -、-CH2 O-、-CH2 CH2 -、-(CH2 )4 -、-CF2 -O-、-O-CF2 -、-CF2 CF2 -、-CH=CH-、-CF=CF-、-CH=CH-COO-、-OCO-CH=CH-或-C≡C-,該等基團視情況經一或多個F取代,
較佳為-COO-、-OCO-或-O-CO-O-,
更佳為-COO-或-OCO-。
d 表示1至15之整數,較佳奇數(亦即非偶數)整數,且更佳3、5、7或9。
In a more preferred embodiment, the LC medium according to the invention comprises one or more compounds of formula IV,
R 41 -A 41 -A 42 -Z 41- (CH 2 ) d -Z 42 -A 43 -A 44 -R 42 IV
among them
R 41 and R 42 each have independently one of the meanings given above for R 21 under Formula II,
A 41 to A 44 each have, independently of one another, one of the meanings given above for A 21 under Formula II,
Z 41 and Z 42 are each independently -COO-, -OCO-, -O-CO-O-, -OCH 2- , -CH 2 O-, -CH 2 CH 2 -,-( CH 2 ) 4- , -CF 2 -O-, -O-CF 2- , -CF 2 CF 2- , -CH = CH-, -CF = CF-, -CH = CH-COO-, -OCO- CH = CH- or -C≡C-, these groups are optionally substituted by one or more F,
Preferably -COO-, -OCO- or -O-CO-O-,
More preferably, it is -COO- or -OCO-.
d represents an integer from 1 to 15, preferably an odd (ie, non-even) integer, and more preferably 3, 5, 7, or 9.

較佳的式IV之化合物係選自其中基團(-A41 -A42 -)及(-A43 -A44 -)各自且獨立地選自如上文給出的MG1至MG4之基團的化合物。Preferred compound is selected from formula IV wherein the groups of (-A 41 -A 42 -) and (-A 43 -A 44 -) group are each independently selected as described above and set forth in the MG1 through MG4 Compound.

尤其較佳的式IV之化合物係選自下式之化合物之群:
- 對稱化合物(IVa及IVb):




- 非對稱化合物(IVc):

Particularly preferred compounds of formula IV are selected from the group of compounds of the formula:
-Symmetric compounds (IVa and IVb):




-Asymmetric compounds (IVc):

式IV之化合物係已知的或可根據或以類似於本身已知及描述於有機化學之標準著作(例如Houben-Weyl, Methoden der organischen Chemie, Thieme-Verlag, Stuttgart)中之方法來合成。Compounds of formula IV are known or can be synthesized according to or in a manner similar to standard works known per se and described in organic chemistry (eg Houben-Weyl, Methoden der organischen Chemie, Thieme-Verlag, Stuttgart).

為降低向列型扭曲彎曲相同時保持有利的e/K值,在根據本發明之混合物中除式I之化合物之外還採用式IV之化合物尤其有用。In order to reduce the nematic twist and bend while maintaining a favorable e / K value, it is particularly useful to use a compound of formula IV in addition to the compound of formula I in the mixture according to the invention.

在更佳實施例中,根據本發明之LC介質另外包含一或多種式V之化合物,
R51 -A51 -Z51 -(CH2 )e -Z52 -A52 -(A53 )f -R52 V
其中
R51 及R52 各自且獨立地具有如上文在式II下針對R21 給出之含義中之一者,
A51 至A53 各自且彼此獨立地具有如上文在式II下針對A21 給出之含義中之一者,
Z51 及Z52 在每次出現時各自獨立地為-COO-、-OCO-、-O-CO-O-、-OCH2 -、-CH2 O-、-CH2 CH2 -、-(CH2 )4 -、-CF2 -O-、-O-CF2 -、-CF2 CF2 -、-CH=CH-、-CF=CF-、-CH=CH-COO-、-OCO-CH=CH-或-C≡C-,該等基團視情況經一或多個F取代,
較佳為-COO-、-OCO-或-O-CO-O-,
更佳為-COO-或-OCO-,
e 表示1至15之整數,較佳奇數(亦即非偶數)整數,且更佳3、5、7或9,且
f 表示0或1。
In a more preferred embodiment, the LC medium according to the invention further comprises one or more compounds of formula V,
R 51 -A 51 -Z 51- (CH 2 ) e -Z 52 -A 52- (A 53 ) f -R 52 V
among them
R 51 and R 52 each have, independently, one of the meanings given above for R 21 under Formula II,
A 51 to A 53 each have, independently of one another, one of the meanings given above for A 21 under Formula II,
Z 51 and Z 52 are each independently -COO-, -OCO-, -O-CO-O-, -OCH 2- , -CH 2 O-, -CH 2 CH 2 -,-( CH 2 ) 4- , -CF 2 -O-, -O-CF 2- , -CF 2 CF 2- , -CH = CH-, -CF = CF-, -CH = CH-COO-, -OCO- CH = CH- or -C≡C-, these groups are optionally substituted by one or more F,
Preferably -COO-, -OCO- or -O-CO-O-,
More preferably -COO- or -OCO-,
e represents an integer from 1 to 15, preferably an odd (i.e. non-even) integer, and more preferably 3, 5, 7, or 9, and
f represents 0 or 1.

尤其較佳為其中A51 係選自以下式Va'至Vf'之群及式Vd'及Ve'之鏡像的式V之化合物
Particularly preferred are compounds of formula V in which A 51 is selected from the group of formulae Va 'to Vf' and mirror images of formulas Vd 'and Ve'.

較佳地式V中之R51 及R52 經選定為H、F、Cl、CN、NO2 、OCH3 、COCH3 、COC2 H5 、COOCH3 、COOC2 H5 、CF3 、C2 F5 、OCF3 、OCHF2 及OC2 F5 ,特別為H、F、Cl、CN、OCH3 及OCF3 ,尤其為H、F、CN及OCF3Preferably, R 51 and R 52 in formula V are selected as H, F, Cl, CN, NO 2 , OCH 3 , COCH 3 , COC 2 H 5 , COOCH 3 , COOC 2 H 5 , CF 3 , C 2 F 5 , OCF 3 , OCHF 2 and OC 2 F 5 , especially H, F, Cl, CN, OCH 3 and OCF 3 , especially H, F, CN and OCF 3 .

較佳的式V之化合物係選自式VA至VD、較佳式VA及/或VC、最佳式VC之化合物之群,

其中
LG51 為Z51 -(CH2 )z -Z52
(F)0 表示H,且
(F)1 表示F。
且其他參數具有上文給出之各別含義,包括較佳含義。
Preferred compounds of formula V are selected from the group of compounds of formulas VA to VD, preferably of formula VA and / or VC, and of formula VC,

among them
LG 51 is Z 51- (CH 2 ) z -Z 52 ,
(F) 0 represents H, and
(F) 1 means F.
And other parameters have their respective meanings given above, including better meanings.

較佳地Z51 -(CH2 )z -Z52 表示-O-CO-(CH2 )n -CO-O-、-O-(CH2 )n -O-或-(CH2 )n -,更佳地為-O-CO-(CH2 )n -CO-O-,其中n表示3、5、7或9。Preferably, Z 51- (CH 2 ) z -Z 52 represents -O-CO- (CH 2 ) n -CO-O-, -O- (CH 2 ) n -O- or-(CH 2 ) n- , More preferably -O-CO- (CH 2 ) n -CO-O-, wherein n represents 3, 5, 7, or 9.

尤其較佳的式VA之化合物係選自式VA-1至VA-3之化合物之群:

其中參數具有上文給出之各別含義,包括較佳含義。
Particularly preferred compounds of formula VA are selected from the group of compounds of formulas VA-1 to VA-3:

The parameters have the respective meanings given above, including preferred meanings.

尤其較佳的式VB之化合物係選自式VB-1至VB-3之化合物之群:


其中參數具有上文給出之各別含義,包括較佳含義。
Particularly preferred compounds of formula VB are selected from the group of compounds of formulas VB-1 to VB-3:


The parameters have the respective meanings given above, including preferred meanings.

式VC之化合物係極佳的。且其中尤其較佳的化合物係選自式VC-1至VC-3之化合物之群:

其中參數具有上文給出之各別含義,包括較佳含義。
Compounds of formula VC are excellent. And particularly preferred compounds among them are selected from the group of compounds of the formulae VC-1 to VC-3:

The parameters have the respective meanings given above, including preferred meanings.

可根據或以類似於本身已知及描述於有機化學之標準著作(例如Houben-Weyl, Methoden der organischen Chemie, Thieme-Verlag, Stuttgart)中之方法來合成式V之化合物。較佳製備方法揭示於例如WO2015/036079 A1中。Compounds of formula V can be synthesized according to or in a manner similar to standard writings known per se and described in organic chemistry (for example, Houben-Weyl, Methoden der organischen Chemie, Thieme-Verlag, Stuttgart). A preferred method of preparation is disclosed, for example, in WO2015 / 036079 A1.

在一更佳實施例中,根據本發明之LC介質另外包含一或多種式VI之化合物,
R61 -A61 -A62 -(CH2 )g -Z61 -A63 -A64 -(A65 )h -R62 VI
其中
R61 及R62 各自且獨立地具有如上文在式II下針對R21 給出之含義中之一者,
A61 至A64 各自且獨立地具有如上文在式II下針對A21 給出之含義中之一者,
Z61 表示-O-、-COO-、-OCO-、-O-CO-O-、-OCH2 -、-CH2 O、-CH2 CH2 -、-(CH2 )4 -、-CF2 -O-、-O-CF2 -、-CF2 CF2 -、-CH=CH-、-CF=CF-、-CH=CH-COO-、-OCO-CH=CH-或-C≡C-,該等基團視情況經一或多個F、S及/或Si取代,
較佳為-O-、-COO-、-OCO-或-O-CO-O-,
更佳為-O-、-COO-或-OCO-,最佳為-COO-或-OCO-,
h 表示0或1,且
g 表示1至15之整數,較佳奇數(亦即非偶數)整數,且更佳3、5、7或9。
In a more preferred embodiment, the LC medium according to the present invention further comprises one or more compounds of formula VI,
R 61 -A 61 -A 62- (CH 2 ) g -Z 61 -A 63 -A 64- (A 65 ) h -R 62 VI
among them
R 61 and R 62 each have independently one of the meanings given above for R 21 under Formula II,
A 61 to A 64 each have independently one of the meanings given above for A 21 under Formula II,
Z 61 represents -O-, -COO-, -OCO-, -O-CO-O-, -OCH 2- , -CH 2 O, -CH 2 CH 2 -,-(CH 2 ) 4- , -CF 2 -O-, -O-CF 2- , -CF 2 CF 2- , -CH = CH-, -CF = CF-, -CH = CH-COO-, -OCO-CH = CH- or -C≡ C-, these groups are optionally substituted with one or more F, S and / or Si,
Preferably -O-, -COO-, -OCO-, or -O-CO-O-,
More preferably -O-, -COO- or -OCO-, most preferably -COO- or -OCO-,
h is 0 or 1, and
g represents an integer from 1 to 15, preferably an odd (ie, non-even) integer, and more preferably 3, 5, 7, or 9.

較佳的式VI之化合物係選自其中基團 (-A61 -A62 -)及(-A63 -A64 -)各自且獨立地選自上文給出的MG1至MG4之基團的化合物。Preferred compounds of formula VI are selected from the group wherein the groups (-A 61 -A 62- ) and (-A 63 -A 64- ) are each and independently selected from the groups MG1 to MG4 given above. Compound.

更佳的係其中h表示0且式VI中之基團(-A61 -A62 -)及(-A63 -A64 -(A65 )h )不相同或不為鏡像或其中h表示1的式VI之化合物。More preferred are those in which h represents 0 and the groups (-A 61 -A 62- ) and (-A 63 -A 64- (A 65 ) h ) in Formula VI are different or not mirror images or where h represents 1 Compound of Formula VI.

尤其較佳的式VI之化合物係選自下式之化合物之群:

Particularly preferred compounds of formula VI are selected from the group of compounds of the formula:

可根據或以類似於本身已知及描述於有機化學之標準著作(例如Houben-Weyl, Methoden der organischen Chemie, Thieme-Verlag, Stuttgart)中之方法來合成式VI之化合物。較佳地,式VI之化合物係根據或以類似於在WO 2014/005672 A1中揭示之方法來合成。Compounds of formula VI can be synthesized according to or in a manner similar to standard writings known per se and described in organic chemistry (for example, Houben-Weyl, Methoden der organischen Chemie, Thieme-Verlag, Stuttgart). Preferably, the compound of formula VI is synthesized according to or in a manner similar to that disclosed in WO 2014/005672 A1.

為獲得較高澄清點亦及有利的e/K值,在根據本發明之混合物中除式I之化合物之外還採用式VI之化合物尤其有用。In order to obtain higher clearing points and advantageous e / K values, it is particularly useful to use compounds of formula VI in addition to compounds of formula I in the mixtures according to the invention.

在一更佳實施例中,根據本發明之LC介質另外包含一種、兩種、三種或更多種式VII之化合物,
R71 -A71 -Z71 -A72 -(Z72 -A73 )i -(CH2 )j -(A74 -Z73 -)k -A75 -Z74 -A76 -R72 VII
其中
R71 及R72 各自且獨立地具有如上文在式II下針對R21 給出之含義中之一者,
A71 至A76 各自且獨立地具有如上文在式II下針對A21 給出之含義中之一者,
Z71 至Z74 各自且獨立地表示-COO-、-OCO-、-O-CO-O-、-OCH2 -、-CH2 O-、-OCF2 -、-CF2 O-、-CH2 CH2 -、-(CH2 )4 -、-CF2 CF2 -、-CH=CH-、-CF=CF-、-CH=CH-COO-、-OCO-CH=CH-或-C≡C-,該等基團視情況經一或多個F、S及/或Si取代,或表示單鍵,
較佳為-COO-、-OCO-、-O-CO-O-、-OCF2 -、-CF2 O-或單鍵
更佳為-COO-、-OCO-、-OCF2 -、-CF2 O-或單鍵,
限制條件為Z71 至Z74 中之至少一個不為單鍵,
j 表示1至15之整數,較佳奇數(亦即非偶數)整數,且更佳3、5、7或9,且
i及k 各自且獨立地表示0或1。
In a more preferred embodiment, the LC medium according to the present invention further comprises one, two, three or more compounds of formula VII,
R 71 -A 71 -Z 71 -A 72 - (Z 72 -A 73) i - (CH 2) j - (A 74 -Z 73 -) k -A 75 -Z 74 -A 76 -R 72 VII
among them
R 71 and R 72 each and independently have one of the meanings given above for R 21 under Formula II,
A 71 to A 76 each and independently have one of the meanings given above for A 21 under Formula II,
Z 71 to Z 74 each independently represent -COO-, -OCO-, -O-CO-O-, -OCH 2- , -CH 2 O-, -OCF 2- , -CF 2 O-, -CH 2 CH 2 -,-(CH 2 ) 4- , -CF 2 CF 2- , -CH = CH-, -CF = CF-, -CH = CH-COO-, -OCO-CH = CH- or -C ≡C-, these groups are optionally substituted by one or more F, S and / or Si, or represent a single bond,
-COO-, -OCO-, -O-CO-O-, -OCF 2- , -CF 2 O- or a single bond is more preferred -COO-, -OCO-, -OCF 2- , -CF 2 O- or single bond,
The restriction is that at least one of Z 71 to Z 74 is not a single bond,
j represents an integer from 1 to 15, preferably an odd (i.e., non-even) integer, and more preferably 3, 5, 7, or 9, and
i and k each represent 0 or 1 independently.

較佳的式VII之化合物係選自其中基團-A71 -Z71 -A72 -(Z72 -A73 )i -、-(A74 -Z73 -)k -A75 -Z74 -A76 -中之至少一者選自MGa至MGn及其鏡像之基團的化合物


其中
較佳地L在每次出現時彼此獨立地為F、Cl、CN或視情況氟化之具有1至7個C原子之烷基、烷氧基或烷醯基,極佳為F、Cl、CN、CH3 、C2 H5 、OCH3 、OC2 H5 、COCH3 、COC2 H5 、COOCH3 、COOC2 H5 、CF3 、OCF3 、OCHF2 、OC2 F5 ,尤其為F、Cl、CN、CH3 、C2 H5 、OCH3 、COCH3 及OCF3 ,最佳為F、Cl、CH3 、OCH3 及COCH3 ,且r在每次出現時彼此獨立地為0、1、2、3或4,較佳為0、1或2。
Preferred compounds of formula VII selected lines wherein the group -A 71 -Z 71 -A 72 - ( Z 72 -A 73) i -, - (A 74 -Z 73 -) k -A 75 -Z 74 - A 76 -at least one compound selected from the group consisting of MGa to MGn and its mirror image


Among them, preferably L is independently F, Cl, CN or optionally fluorinated alkyl, alkoxy or alkylfluorenyl having 1 to 7 C atoms, and most preferably F, Cl in each occurrence. , CN, CH 3 , C 2 H 5 , OCH 3 , OC 2 H 5 , COCH 3 , COC 2 H 5 , COOCH 3 , COOC 2 H 5 , CF 3 , OCF 3 , OCHF 2 , OC 2 F 5 , especially F, Cl, CN, CH 3 , C 2 H 5 , OCH 3 , COCH 3 and OCF 3 , most preferably F, Cl, CH 3 , OCH 3 and COCH 3 , and r are independent of each other at each occurrence It is 0, 1, 2, 3, or 4, preferably 0, 1, or 2.

其中L較佳為F、Cl、CH3 、OCH3 及COCH3 Among them, L is preferably F, Cl, CH 3 , OCH 3 and COCH 3 .

更佳的係其中式VII中之基團-A71 -Z71 -A72 -(Z72 -A73 )i -及-(A74 -Z73 -)k -A75 -Z74 -A76 -相同或為鏡像的式VII之化合物,限制條件為Z71 至Z74 中之至少一者不為單鍵。Better system of formula VII wherein the group -A 71 -Z 71 -A 72 - ( Z 72 -A 73) i - and - (A 74 -Z 73 -) k -A 75 -Z 74 -A 76 A compound of formula VII that is the same or mirror image, with the proviso that at least one of Z 71 to Z 74 is not a single bond.

更佳的係式VII之化合物,其中i及k皆表示1,更佳地i及k中之一個表示0且另一個表示1,最佳地i及k皆表示0。A more preferred compound of formula VII, wherein i and k each represent a 1, more preferably one of i and k represents 0 and the other represents 1, and most preferably i and k each represent 0.

尤其較佳的式VII之化合物係選自下式之化合物之群:



其中R71 及R72 各自且獨立地表示F或CN。
Particularly preferred compounds of formula VII are selected from the group of compounds of the formula:



Here, R 71 and R 72 each independently represent F or CN.

可根據或以類似於本身已知及描述於有機化學之標準著作(例如Houben-Weyl, Methoden der organischen Chemie, Thieme-Verlag, Stuttgart)中之方法來合成式VII之化合物。較佳地,式VII之化合物係根據或以類似於在例如WO 2013/174478 A1中揭示之方法合成。Compounds of formula VII can be synthesized according to or in a manner similar to standard works known per se and described in organic chemistry (for example, Houben-Weyl, Methoden der organischen Chemie, Thieme-Verlag, Stuttgart). Preferably, the compound of formula VII is synthesized according to or in a manner similar to that disclosed in, for example, WO 2013/174478 A1.

在一更佳實施例中,根據本發明之介質視情況包含一或多種對掌性摻雜劑,尤其當用於撓曲電裝置中時。In a more preferred embodiment, the medium according to the invention optionally contains one or more pairs of palmar dopants, especially when used in flexure electrical devices.

對掌性化合物誘導具有螺距(P0 )之對掌性向列型結構,該螺距在一級近似下與所使用之對掌性材料濃度(c)成反比。此關係之比例之常數稱為對掌性物質之螺旋狀扭轉力(helical twisting power,HTP)且由以下等式定義
HTP ≡ 1 / (c·P0 ) (1)
其中
c 為對掌性化合物之濃度。
The palmar compound induces a palmar nematic structure with a pitch (P 0 ), which is inversely proportional to the concentration of the palmitic material (c) used under a first order approximation. The constant of the ratio of this relationship is called the helical twisting power (HTP) of the palm material and is defined by the following equation
HTP ≡ 1 / (c · P 0 ) (1)
among them
c is the concentration of palmar compounds.

舉例而言,均勻橫向螺旋結構使用具有通常在0.2 µm至1 µm範圍內、較佳1.0 µm或更小、尤其0.5 µm或更小之短螺距的對掌性向列型液晶實現,該對掌性向列型液晶以其螺旋軸平行於液晶單元之基板(例如玻璃板)之方式單向配向。在此組態中,對掌性向列型液晶之螺旋軸等效於雙折射板之光軸。For example, a uniform lateral spiral structure is achieved using a palmitic nematic liquid crystal having a short pitch, typically in the range of 0.2 μm to 1 μm, preferably 1.0 μm or less, especially 0.5 μm or less. In-line liquid crystals are unidirectionally aligned in such a manner that the spiral axis thereof is parallel to the substrate (such as a glass plate) of the liquid crystal cell. In this configuration, the spiral axis of a palmitic nematic liquid crystal is equivalent to the optical axis of a birefringent plate.

較佳的係具有高螺旋狀扭轉力(HTP)之對掌性摻雜劑,尤其係在WO 98/00428中揭示之對掌性摻雜劑。The preferred are dopant dopants having high helical twisting force (HTP), especially the dopant dopants disclosed in WO 98/00428.

通常所使用之對掌性摻雜劑為例如可商購的R/S-5011、CD-1、R/S-811及CB-15(來自Merck KGaA, Darmstadt, Germany)。Commonly used dopants are, for example, commercially available R / S-5011, CD-1, R / S-811, and CB-15 (from Merck KGaA, Darmstadt, Germany).

在另一較佳實施例中,對掌性摻雜劑較佳選自式VIII,

及/或式IX,

包括各別(S,S)對映異構體,
其中E及F各自獨立地為1,4-伸苯基或反-1,4-伸環己基,v為0或1,Z0 為-COO-、-OCO-、-CH2 CH2 -或單鍵,且R為具有1至12個C原子之烷基、烷氧基或烷醯基。
In another preferred embodiment, the palm dopant is preferably selected from Formula VIII,

And / or formula IX,

Including the individual (S, S) enantiomers,
Where E and F are each independently 1,4-phenylene or trans-1,4-cyclohexyl, v is 0 or 1, and Z 0 is -COO-, -OCO-, -CH 2 CH 2 -or Single bond, and R is an alkyl, alkoxy or alkylfluorenyl group having 1 to 12 C atoms.

式VIII之化合物及其合成描述於WO 98/00428中。式IX之化合物及其合成描述於GB 2,328,207中。Compounds of formula VIII and their synthesis are described in WO 98/00428. Compounds of formula IX and their synthesis are described in GB 2,328,207.

上述對掌性摻雜劑R/S-5011及式VIII及IX之化合物展現出極高螺旋狀扭轉力(HTP)且因而尤其適用於本發明之目的。The aforementioned palmitic dopants R / S-5011 and the compounds of the formulae VIII and IX exhibit extremely high helical twisting forces (HTP) and are therefore particularly suitable for the purposes of the present invention.

液晶介質較佳包含較佳1至5、尤其1至3、極佳1或2種對掌性摻雜劑,其較佳選自上式VIII及/或式IX及/或R-5011或S-5011,極佳地對掌性化合物為R-5011、或S-5011。The liquid crystal medium preferably contains 1 to 5, especially 1 to 3, and 1 or 2 palmitic dopants, which are preferably selected from the above formula VIII and / or formula IX and / or R-5011 or S -5011, which is an excellent palm compound R-5011, or S-5011.

液晶介質中之對掌性化合物之量較佳為總混合物之0.1重量%至15重量%、尤其0.5重量%至10重量%、極佳1重量%至5重量%。The amount of the palmitic compound in the liquid crystal medium is preferably 0.1% to 15% by weight, especially 0.5% to 10% by weight, and very preferably 1% to 5% by weight of the total mixture.

較佳,LC介質包含一或多種選自如下所示之化合物的向列型LC化合物:


其中
R2A 表示H、具有1至15個C原子之烷基或烷氧基,另外其中該等基團中之一或多個CH2 基團可各自彼此獨立地經以下基團置換:-C≡C-、-CF2 O-、-CH=CH-、、-O-、-CO-O-或-O-CO-,置換方式為使得O原子彼此不直接連接,且另外其中一或多個H原子可經鹵素置換,
L1 及L2 各自彼此獨立地表示F、Cl、CF3 或CHF2 ,較佳各自表示F,
Z2 及Z2 ' 各自彼此獨立地表示單鍵、-CH2 CH2 -、-CH=CH-、-C≡C-、-CF2 O-、-OCF2 -、-CH2 O-、-OCH2 -、-COO-、-OCO-、-C2 F4 -、-CF=CF-或-CH=CHCH2 O-,
p 表示0、1或2,
q 表示0或1,
(O)Cv H2v+1 表示OCv H2v+1 或Cv H2v+1 ,且
v 表示1至6。
Preferably, the LC medium comprises one or more nematic LC compounds selected from the compounds shown below:


among them
R 2A represents H, an alkyl group or an alkoxy group having 1 to 15 C atoms, and in addition, one or more of the CH 2 groups in these groups may be independently replaced with each other by the following groups: -C≡ C-, -CF 2 O-, -CH = CH-, , , -O-, -CO-O- or -O-CO-, the substitution method is such that O atoms are not directly connected to each other, and one or more H atoms can be replaced by halogen,
L 1 and L 2 each independently represent F, Cl, CF 3 or CHF 2 , preferably each represents F,
Z 2 and Z 2 ' each independently represent a single bond, -CH 2 CH 2- , -CH = CH-, -C≡C-, -CF 2 O-, -OCF 2- , -CH 2 O-, -OCH 2- , -COO-, -OCO-, -C 2 F 4- , -CF = CF- or -CH = CHCH 2 O-,
p is 0, 1, or 2,
q means 0 or 1,
(O) C v H 2v + 1 means OC v H 2v + 1 or C v H 2v + 1 , and
v represents 1 to 6.

液晶介質可以常用濃度含有其他添加劑,如,例如,安定劑、抑制劑、表面活性化合物、潤滑劑、濕潤劑、分散劑、疏水劑、黏著劑、流動改進劑、消泡劑、脫氣劑、稀釋劑、反應性稀釋劑、助劑、著色劑、染料、顏料或奈米顆粒。以總混合物計此等其他組分之總濃度在0.1%至10%、較佳0.1%至6%範圍內。所用之個別化合物之濃度各自較佳在0.1%至3%之範圍內。The liquid crystal medium may contain other additives in common concentrations, such as, for example, stabilizers, inhibitors, surface-active compounds, lubricants, wetting agents, dispersants, hydrophobic agents, adhesives, flow improvers, defoamers, deaerators, Diluents, reactive diluents, auxiliaries, colorants, dyes, pigments or nano particles. The total concentration of these other components is in the range of 0.1% to 10%, preferably 0.1% to 6%, based on the total mixture. The concentrations of the individual compounds used are each preferably in the range of 0.1% to 3%.

對於本申請案中之液晶介質之液晶組分及化合物的濃度之值及範圍而言,未考慮此等及類似添加劑之濃度。此亦適用於在混合物中使用之二向色染料之濃度,當分別指定主體介質之化合物及組分之濃度時,二向色染料之濃度不計算在內。各別添加劑之濃度始終相對於最終摻雜混合物來給出。For the values and ranges of the concentration of the liquid crystal components and compounds of the liquid crystal medium in this application, the concentrations of these and similar additives are not considered. This also applies to the concentration of dichroic dyes used in the mixture. When the concentrations of the compounds and components of the host medium are separately specified, the concentration of dichroic dyes is not calculated. The concentrations of the individual additives are always given relative to the final doping mixture.

一般而言,根據本申請案之介質中之所有化合物之總濃度為100%。In general, the total concentration of all compounds in the medium according to the application is 100%.

根據本發明之液晶介質由若干化合物、較佳2至40種、更佳3至30種且最佳4至25種化合物組成。The liquid crystal medium according to the present invention is composed of several compounds, preferably 2 to 40, more preferably 3 to 30, and most preferably 4 to 25 compounds.

根據本發明之介質展現較高彈性常數k11 之值及較高撓曲電係數e。液晶介質較佳展現k11 ≤100 pN,較佳≤20 pN。The medium according to the invention exhibits a higher value of the elastic constant k 11 and a higher deflection coefficient e. The liquid crystal medium preferably exhibits k 11 ≦ 100 pN, and preferably ≦ 20 pN.

液晶介質較佳展現k33 ≤100 pN,較佳≤15 pN。The liquid crystal medium preferably exhibits k 33 ≤ 100 pN, and preferably ≤ 15 pN.

液晶介質較佳展現撓曲電係數│e11 │≥0.2 pC/m,較佳≥1 pC/m。The liquid crystal medium preferably exhibits a flexural coefficient │e 11 ≧ 0.2 pC / m, and preferably ≧ 1 pC / m.

液晶介質較佳展現撓曲電係數│e33 │≥0.2 pC/m,較佳≥2 pC/m。The liquid crystal medium preferably exhibits a flexural coefficient │e 33 │ ≧ 0.2 pC / m, and preferably ≧ 2 pC / m.

液晶介質較佳展現柔性-彈性比率(ē/K)在1至10 V-1 範圍內、較佳在1至7 V-1 範圍內、更佳在1至5 V-1 範圍內。The liquid crystal medium preferably exhibits a flexibility-elasticity ratio (ē / K) in the range of 1 to 10 V -1 , preferably in the range of 1 to 7 V -1 , and more preferably in the range of 1 to 5 V -1 .

根據本發明之介質展現至多60℃及更高、較佳至多65℃及更高且更佳至多70℃及更高之高澄清點。The medium according to the invention exhibits a high clearing point of at most 60 ° C and higher, preferably at most 65 ° C and higher and more preferably at most 70 ° C and higher.

根據本發明之介質展現30℃及更大、較佳35℃及更大或甚至40℃或更大之寬向列相。The medium according to the invention exhibits a wide nematic phase of 30 ° C and higher, preferably 35 ° C and higher or even 40 ° C or higher.

根據本發明之介質展現低於20℃或更小、較佳低於15℃或更小且更佳低於0℃或更小之NTB 相。The medium according to the invention exhibits an N TB phase below 20 ° C or less, preferably below 15 ° C or less and more preferably below 0 ° C or less.

根據本發明之介質展現在室溫下多於100小時、較佳多於250小時或多於1000小時之高抗結晶穩定性。The medium according to the invention exhibits a high resistance to crystallization at room temperature for more than 100 hours, preferably more than 250 hours or more than 1000 hours.

根據本發明之介質即使在低溫下亦展現較高抗結晶穩定性(LTS)。相應地,介質即使在低至0℃、較佳低至-10℃更佳低至-20℃之溫度下亦不結晶。The medium according to the invention exhibits a high resistance to crystallisation (LTS) even at low temperatures. Accordingly, the medium does not crystallize even at temperatures as low as 0 ° C, preferably as low as -10 ° C, and more preferably as low as -20 ° C.

在一較佳實施例中,LC介質包含:
· 1至10、較佳1至5、更佳1或3、最佳1或2種式I之化合物。液晶介質中之式I之化合物之量整體上較佳在總混合物之5至50重量%範圍內、尤其6至30重量%範圍內、尤其7至20重量%範圍內,

· 視情況1至10、較佳1至5、更佳1或3、最佳1或2種式II之化合物,該等式II之化合物較佳選自其中式II中之(-A21 -A22 -)及(-A23 -A24 -)相同或為鏡像的式II之化合物,更佳為式II'a-5及/或II'a-6之化合物。若存在,則液晶介質中之式II之化合物之量較佳在總混合物之0至30重量%範圍內、更佳1至20重量%範圍內、甚至更佳2至10重量%範圍內,
及/或
· 視情況1至10、較佳1至5、更佳1或3、最佳1或2種式III之化合物,該等式III之化合物較佳選自上式IIIc-2及/或IIIc-3之對稱化合物。若存在,則液晶介質中之式III之化合物之量較佳在總混合物之1至50重量%範圍內、更佳5至30重量%範圍內、甚至更佳10至20重量%範圍內,
及/或
· 視情況1至10、較佳1至5、更佳1或3、最佳1或2種式IV之化合物,該等式IV之化合物較佳選自對稱化合物IVb及/或非對稱化合物IVc,更佳選自式IVb-5、IVc-2、IVc-3、IVc-12及/或IVc-15。若存在,則液晶介質中之式IV之化合物之量較佳在總混合物之1至98重量%範圍內、更佳20至80重量%範圍內、甚至更佳30至60重量%範圍內,
及/或
· 視情況1至6、尤其2至5、極佳3或4種式V之化合物,該等式V之化合物較佳選自上式VA-1、VC-2及/或VC-3。若存在,則液晶介質中之式V之化合物之量較佳在總混合物之1至70重量%範圍內、更佳10至60重量%範圍內、甚至更佳20至50重量%範圍內,
及/或
· 視情況1至10、較佳1至5、更佳1或3、最佳1或2種來自上式VI之化合物,較佳形式為式VI-4、VI-5、VI-7及/或VI-8之化合物。若存在,則液晶介質中之式VI之化合物之量較佳為總混合物之1至40重量%、尤其5至25重量%、極佳10至15重量%,
及/或
· 視情況1至10、較佳1至5、更佳1或3、最佳1或2種來自上式VII之化合物,較佳形式為式VII-4、VII-5及/或VII-8之化合物。若存在,則液晶介質中之式VII之化合物之量較佳為總混合物之1至35重量%、尤其5至25重量%、極佳10至15重量%,
及/或
· 視情況1至5、尤其1至3、極佳1或2種對掌性摻雜劑,其較佳選自上式VIII及/或式IX及/或R-5011或S-5011,極佳對掌性化合物為R-5011或S-5011。若存在,液晶介質中之對掌性化合物之量較佳為總混合物之1至15重量%、尤其0.5至10重量%、極佳0.1至5重量%,
及/或
視情況至多25、尤其至多20、極佳至多15種選自式X之化合物之不同化合物。若存在,液晶介質中之式X之化合物之量整體上較佳為總混合物之1至50重量%、尤其5至30重量%、極佳10至25重量%,
及/或
· 視情況呈常用濃度之其他添加劑,諸如安定劑、抗氧化劑等。若存在,則按總混合物計此等其他組分之總濃度在0.1%至10%、較佳0.1%至6%範圍內。所使用之個別化合物之濃度各自較佳在0.1%至3%範圍內。
In a preferred embodiment, the LC medium includes:
1 to 10, preferably 1 to 5, more preferably 1 or 3, most preferably 1 or 2 compounds of formula I. The amount of the compound of formula I in the liquid crystal medium as a whole is preferably in the range of 5 to 50% by weight of the total mixture, especially in the range of 6 to 30% by weight, especially in the range of 7 to 20% by weight
And · as the case may be 1 to 10, preferably 1 to 5, more preferably 1 or 3, and most preferably 1 or 2 compounds of formula II, the compounds of formula II are preferably selected from among (-A 21 -A 22- ) and (-A 23 -A 24- ) are the same or mirror-image compounds of formula II, more preferably compounds of formula II'a-5 and / or II'a-6. If present, the amount of the compound of formula II in the liquid crystal medium is preferably in the range of 0 to 30% by weight, more preferably 1 to 20% by weight, even more preferably 2 to 10% by weight,
And / or, as the case may be, 1 to 10, preferably 1 to 5, more preferably 1 or 3, and most preferably 1 or 2 compounds of formula III, and the compounds of formula III are preferably selected from the above formula IIIc-2 and / Or IIIc-3 symmetrical compounds. If present, the amount of the compound of formula III in the liquid crystal medium is preferably in the range of 1 to 50% by weight, more preferably 5 to 30% by weight, even more preferably 10 to 20% by weight,
And / or, as the case may be, 1 to 10, preferably 1 to 5, more preferably 1 or 3, and most preferably 1 or 2 compounds of formula IV, which compounds of formula IV are preferably selected from symmetric compounds IVb and / or non- The symmetric compound IVc is more preferably selected from Formula IVb-5, IVc-2, IVc-3, IVc-12 and / or IVc-15. If present, the amount of the compound of formula IV in the liquid crystal medium is preferably in the range of 1 to 98% by weight, more preferably 20 to 80% by weight, even more preferably 30 to 60% by weight,
And / or, as the case may be 1 to 6, especially 2 to 5, excellent 3 or 4 compounds of formula V, the compounds of formula V are preferably selected from the above formulas VA-1, VC-2 and / or VC- 3. If present, the amount of the compound of formula V in the liquid crystal medium is preferably within a range from 1 to 70% by weight, more preferably from 10 to 60% by weight, even more preferably from 20 to 50% by weight,
And / or, as appropriate, 1 to 10, preferably 1 to 5, more preferably 1 or 3, and most preferably 1 or 2 compounds from the above formula VI, preferably in the formulae VI-4, VI-5, VI- 7 and / or VI-8 compounds. If present, the amount of the compound of formula VI in the liquid crystal medium is preferably 1 to 40% by weight, especially 5 to 25% by weight, very preferably 10 to 15% by weight,
And / or, as appropriate, 1 to 10, preferably 1 to 5, more preferably 1 or 3, and most preferably 1 or 2 compounds from the above formula VII, preferably in the form of formulas VII-4, VII-5, and / or Compound of VII-8. If present, the amount of the compound of formula VII in the liquid crystal medium is preferably from 1 to 35% by weight, especially from 5 to 25% by weight, very preferably from 10 to 15% by weight,
And / or, as the case may be, 1 to 5, especially 1 to 3, excellent 1 or 2 types of palmar dopants, preferably selected from the above formula VIII and / or formula IX and / or R-5011 or S- 5011, an excellent palmar compound is R-5011 or S-5011. If present, the amount of the palmitic compound in the liquid crystal medium is preferably 1 to 15% by weight, especially 0.5 to 10% by weight, and very preferably 0.1 to 5% by weight,
And / or up to 25, especially up to 20, and preferably up to 15 different compounds selected from the compounds of formula X, as the case may be. If present, the amount of the compound of formula X in the liquid crystal medium as a whole is preferably from 1 to 50% by weight, especially from 5 to 30% by weight, very preferably from 10 to 25% by weight,
And / or · other additives, such as stabilizers, antioxidants, etc., at commonly used concentrations, as appropriate. If present, the total concentration of these other components is in the range of 0.1% to 10%, preferably 0.1% to 6%, based on the total mixture. The concentrations of the individual compounds used are each preferably in the range of 0.1% to 3%.

在另一較佳實施例中,本發明之LC介質僅由選自式I至X之化合物組成,極佳地LC介質僅由選自式I至IX之化合物組成。In another preferred embodiment, the LC medium of the present invention consists only of a compound selected from the formulae I to X, and most preferably the LC medium consists of a compound selected from the formulae I to IX.

在另一較佳實施例中,本發明之LC介質僅由選自式I至X之化合物組成,其中該等化合物中之每一者均不含有CN基團。眾所周知當考慮有源驅動時含氰基材料具有問題。此係由於VHR(電壓保持率)降低亦及其他可靠性相關參數,諸如圖像殘留。不含氰基之材料的另一優點為其一般毒性較小,且對環境較友好。此使得不含氰基之材料的合成及後續裝運與含氰基材料相比更有吸引力。In another preferred embodiment, the LC medium of the present invention consists only of compounds selected from Formulae I to X, wherein each of these compounds does not contain a CN group. It is well known that cyano-containing materials have problems when considering active driving. This is due to the decrease in VHR (Voltage Holding Rate) and other reliability related parameters, such as image sticking. Another advantage of cyano-free materials is that they are generally less toxic and more environmentally friendly. This makes the synthesis and subsequent shipment of cyano-free materials more attractive than cyano-containing materials.

以習知方式混合形成根據本發明之LC介質之化合物。通常,將用量較小之所需量的化合物溶解於用量較大之化合物中。若溫度高於以較高濃度使用之化合物之澄清點,則特別易於觀測到溶解過程之完成。然而,亦可能藉由其他習知方式來製備介質,例如,使用所謂預混合物,其可以係例如化合物之同源介質或共晶介質,或使用所謂的多瓶系統,其組分本身為即用介質。因此本發明亦關於一種用於製備如上文及下文所描述之LC介質之方法。The compounds are mixed in a conventional manner to form the LC medium according to the invention. Generally, a smaller amount of the required compound is dissolved in a larger amount of the compound. If the temperature is above the clearing point of the compound used at a higher concentration, it is particularly easy to observe the completion of the dissolution process. However, it is also possible to prepare the medium by other known methods, for example, using a so-called premix, which can be, for example, a homologous or eutectic medium of a compound, or a so-called multi-bottle system, whose components are ready-to-use medium. The invention therefore also relates to a method for preparing LC media as described above and below.

特定言之,本發明係關於一種用於製備LC介質之方法,該方法包含混合一或多種式I之化合物之步驟,其中至少一種化合物係選自式II至X之化合物。In particular, the present invention relates to a method for preparing an LC medium, the method comprising the step of mixing one or more compounds of the formula I, wherein at least one compound is selected from the compounds of the formulae II to X.

根據本發明之液晶介質可用於電光學裝置,例如液晶裝置中,諸如STN、TN、AMD-TN、溫度補償、客體-主體、相位變換或表面穩定或聚合物穩定之膽固醇型結構(SSCT、PSCT)顯示器;用於主動及被動光學元件中,如偏光器、補償器、反射器、配向層、濾色器或全像元件;用於黏著劑、具有各向異性機械特性之合成樹脂、化妝品、診斷設備、液晶顏料中;用於裝飾及安全應用中;用於非線性光學器件、光學資訊儲存器或用作對掌性摻雜劑。因此,本發明之另一態樣係包含至少一種式I之化合物之LC介質在電光學裝置中之用途。The liquid crystal medium according to the present invention can be used in an electro-optical device, such as a liquid crystal device, such as STN, TN, AMD-TN, temperature compensation, guest-host, phase shift or surface-stabilized or polymer-stabilized cholesterol-type structures (SSCT, PSCT ) Display; used in active and passive optical elements, such as polarizers, compensators, reflectors, alignment layers, color filters or holographic elements; used in adhesives, synthetic resins with anisotropic mechanical properties, cosmetics, Diagnostic equipment, liquid crystal pigments; used in decorative and safety applications; used in non-linear optics, optical information storage or as a dopant for the palm. Therefore, another aspect of the present invention is the use of an LC medium containing at least one compound of Formula I in an electro-optical device.

因為根據本發明之介質尤其利於用於撓曲電液晶顯示器應用,諸如ULH或USH模式之裝置。This is because the medium according to the present invention is particularly advantageous for use in flex electric liquid crystal display applications, such as devices in ULH or USH mode.

因此本發明之另一目標係包含介質之液晶裝置,較佳撓曲電裝置,該介質包含一或多種式I之化合物。Therefore, another object of the present invention is a liquid crystal device, preferably a flexural electrical device, comprising a medium, the medium comprising one or more compounds of formula I.

根據本發明之一較佳實施例之撓曲電顯示器包含兩個平面平行基板,較佳其內表面上覆蓋有透明導電層,諸如氧化銦錫(ITO)之玻璃板;視情況配向層;及包含一或多種式I之化合物及如上文及下文所描述之對掌性摻雜劑的介質。A flex electric display according to a preferred embodiment of the present invention includes two plane-parallel substrates, preferably the inner surface of which is covered with a transparent conductive layer, such as a glass plate of indium tin oxide (ITO); an alignment layer as appropriate; and A medium comprising one or more compounds of formula I and a palmitic dopant as described above and below.

若電場垂直於螺旋軸施加至此組態中,則光軸在單元之平面中旋轉,類似於強誘電性液晶之引向器在表面穩定強誘電性液晶顯示器中旋轉。If an electric field is applied to this configuration perpendicular to the helix axis, the optical axis rotates in the plane of the cell, similar to a director of a strongly-inductive liquid crystal rotating in a surface-stabilized, strongly-inductive liquid crystal display.

場在引向器中誘導傾斜彎曲結構,其藉由光軸之傾斜來調節。軸之旋轉角度與電場之強度第一近似直接且線性地成比例。當液晶單元置放於正交偏光器之間且不供電狀態下之光軸與偏光器中之一者之吸收軸成22.5°角時,所見之光學效果最佳。此22.5°之角亦為電場之理想旋轉角,因此,藉由反轉電場使光軸旋轉45°,且藉由適當選擇螺旋軸之較佳方向、偏光器之吸收軸及電場之方向的相對定向,可使光軸自平行於一個偏光器切換至兩個偏光器之間的中心角度。隨後在光軸之轉換之總角度為45°時達成最佳對比度。在該情況下,配置可用作可切換的四分之一波板,其條件為光延遲,亦即液晶及單元間隙之有效雙折射之產物,選擇為波長之四分之一。除非另外明確陳述,否則在此上下文中所提及之波長為550 nm,人眼對該波長之靈敏度最高。The field induces a tilt-bend structure in the director, which is adjusted by the tilt of the optical axis. The rotation angle of the shaft is approximately directly and linearly proportional to the strength of the electric field. When the liquid crystal cell is placed between the orthogonal polarizers and the optical axis of the polarizer and the absorption axis of one of the polarizers are at an angle of 22.5 °, the optical effect is best. This 22.5 ° angle is also the ideal rotation angle of the electric field. Therefore, the optical axis is rotated by 45 ° by reversing the electric field, and the relative direction of the preferred axis of the spiral axis, the absorption axis of the polarizer, and the direction of the electric field are appropriately selected. Orientation allows the optical axis to switch from parallel to one polarizer to the center angle between the two polarizers. Optimal contrast is then achieved when the total angle of the optical axis transition is 45 °. In this case, the configuration can be used as a switchable quarter-wave plate, provided that the optical retardation, that is, the product of effective birefringence of the liquid crystal and the cell gap, is selected to be a quarter of the wavelength. Unless explicitly stated otherwise, the wavelength mentioned in this context is 550 nm, and the human eye has the highest sensitivity to this wavelength.

藉由下式良好近似地給出光軸之旋轉角(Φ):
tan Φ = e P0 E / (2 πK )
其中
P0 為膽固醇型液晶之不受干擾螺距,
ē 為傾斜撓曲電係數(e11 )及彎曲撓曲電係數(e33 )之平均值[ē = ½ (e11 + e33 )],
E 為電場強度,且
K 為傾斜彈性常數(k11 )與彎曲彈性常數(k33 )之平均值[K = ½ (k11 + k33 )]
且其中
e /K 稱為柔性-彈性比率。
The rotation angle (Φ) of the optical axis is well approximated by the following formula:
tan Φ = e P 0 E / (2 π K )
among them
P 0 is the undisturbed pitch of the cholesteric liquid crystal,
ē is the average of the inclination deflection coefficient (e 11 ) and the bending deflection coefficient (e 33 ) [ē = ½ (e 11 + e 33 )],
E is the electric field strength, and
K is the average of the inclination elastic constant (k 11 ) and the bending elastic constant (k 33 ) [ K = ½ (k 11 + k 33 )]
And where
e / K is called the flexibility-elasticity ratio.

此旋轉角為撓曲電切換元件中之切換角的一半。This rotation angle is half of the switching angle in the flex electric switching element.

藉由下式良好近似地給出此電光效應之回應時間(τ)
τ = [P0 /(2 π)]2 · γ /K
其中
γ 為與螺旋之畸變相關聯之有效黏度係數。
The response time (τ) of this electro-optic effect is well approximated by the following formula
τ = [P 0 / (2 π)] 2 · γ / K
Where γ is the effective viscosity coefficient associated with the distortion of the spiral.

撓曲電效應之特徵在於快速響應時間(在35℃下的Ton+ Toff )通常在1 ms至10 ms範圍內,較佳< 5ms且甚至更佳< 3ms。其進一步特徵在於極佳的灰階能力。The flexure effect is characterized by a fast response time (T on + T off at 35 ° C.) usually in the range of 1 ms to 10 ms, preferably <5 ms and even better <3 ms. It is further characterized by excellent gray scale capabilities.

存在臨界場(Ec)以解開螺旋,其可自下式獲得
Ec = (π2 / P0 ) · [k22 /(e0 · De)]1/2
其中
k22 為扭轉彈性常數,
e0 為真空之電容率,且
De 為液晶之介電各向異性。
There is a critical field (Ec) to unlock the spiral, which can be obtained from
E c = (π 2 / P 0 ) · [k 22 / (e 0 · De)] 1/2
among them
k 22 is the torsional elastic constant,
e 0 is the permittivity of the vacuum, and
De is the dielectric anisotropy of the liquid crystal.

根據本發明之本發明介質可藉由為專家所已知之方法,諸如表面處理或電場,以其膽固醇型相配向成定向之不同狀態。舉例而言,可將其配向成平面(格朗德讓(Grandjean))狀態,焦點二次曲線狀態或垂直狀態。The medium according to the present invention according to the present invention can be oriented in different states with its cholesterol-type phase by methods known to experts, such as surface treatment or electric field. For example, it can be aligned into a planar (Grandjean) state, a focal conic state, or a vertical state.

顯示器單元中或基板上之液晶或液晶原材料之術語「平面配向」或定向意謂液晶或液晶原材料中之液晶原基團實質上定向成分別平行於單元或基板之平面。The term "plane alignment" or orientation of the liquid crystal or liquid crystal raw material in the display unit or on the substrate means that the original liquid crystal groups in the liquid crystal or liquid crystal raw material are oriented substantially parallel to the plane of the unit or substrate, respectively.

在顯示器單元中或在基板上之液晶或液晶原材料之術語「垂直配向」或定向意謂在液晶或液晶原材料中之液晶原基團實質上定向成分別垂直於單元或基板之平面。The term "vertical alignment" or orientation of a liquid crystal or liquid crystal raw material in a display cell or on a substrate means that the original mesogen groups in the liquid crystal or liquid crystal raw material are substantially oriented perpendicular to the plane of the cell or substrate, respectively.

在下文中例示性地詳細描述根據本發明之一較佳實施例之定向之不同狀態之間的切換。In the following, the switching between different states of the orientation according to a preferred embodiment of the present invention is exemplarily described in detail.

根據此較佳實施例,將樣品置放進入包含兩個塗佈有電極層(例如ITO層)之平面平行玻璃板之單元中,且將其以其膽固醇型相配向成平面狀態,其中將膽固醇型螺旋之軸定向為垂直於單元壁。此狀態亦稱為格朗德讓狀態,且樣品之例如在偏光顯微鏡中可觀測到之結構稱為格朗德讓結構。平面配向可例如藉由表面處理單元壁,例如藉由摩擦及/或用諸如聚醯亞胺之配向層塗佈來達成。According to this preferred embodiment, a sample is placed into a unit containing two planar parallel glass plates coated with an electrode layer (such as an ITO layer), and aligned with its cholesterol-type phase into a planar state, where cholesterol The axis of the profile spiral is oriented perpendicular to the cell wall. This state is also called the Grande Jean state, and the structure of the sample that can be observed, for example, in a polarizing microscope, is called the Grande Jean structure. Planar alignment can be achieved, for example, by surface-treating unit walls, for example by rubbing and / or coating with an alignment layer such as polyimide.

具有高品質之配向及僅極少缺陷之格朗德讓狀態可進一步藉由以下方法實現:將樣品加熱至各向同性相,隨後在接近對掌性向列-各向同性相變之溫度下冷卻至對掌性向列相,且藉由輕微地按壓單元使配向流動。The Grande state with high-quality alignment and few defects can be further achieved by heating the sample to an isotropic phase and then cooling it to a temperature close to the opposite nematic-isotropic phase transition to Opposite palm nematics, and the alignment is flowed by slightly pressing the unit.

在平面狀態中,樣品顯示入射光之選擇性反射,其中反射之中心波長視材料之螺旋狀間距及平均折射率而定。In a planar state, the sample shows selective reflection of incident light, where the center wavelength of the reflection depends on the spiral spacing and average refractive index of the material.

當將例如頻率為10 Hz至1 kHz且振幅為至多12 Vrms /µm之電場施加至電極時,樣品切換成垂直狀態,其中螺旋解開且使分子定向為平行於該場,亦即垂直於該電場平面。在垂直狀態中,當在正常日光中觀視時樣品為透射性的,且當放置於正交偏光器之間時樣品呈現黑色。When an electric field with a frequency of, for example, 10 Hz to 1 kHz and an amplitude of at most 12 V rms / µm is applied to the electrode, the sample switches to a vertical state in which the helix is untied and the molecules are oriented parallel to the field, that is, perpendicular to The electric field plane. In the vertical state, the sample is transmissive when viewed in normal daylight, and the sample appears black when placed between the orthogonal polarizers.

當在垂直狀態中減少或移除電場之後,樣品採用焦點二次曲線結構,其中分子展現螺旋扭轉結構,螺旋軸經取向為垂直於該場,亦即平行於電極平面。亦可藉由在樣品之平面狀態中僅向其施加弱電場來達成焦點二次曲線狀態。在焦點二次曲線狀態中,樣品在正常日光中經觀視時為散射的且在正交偏光器之間呈現為明亮的。When the electric field is reduced or removed in the vertical state, the sample adopts a focal quadratic curve structure, in which the molecules exhibit a spiral twist structure, and the spiral axis is oriented perpendicular to the field, that is, parallel to the electrode plane. The focal quadratic curve state can also be achieved by applying only a weak electric field to the sample in its planar state. In the state of the focal quadratic curve, the sample is scattered when viewed in normal daylight and appears bright between the orthogonal polarizers.

根據本發明之介質之樣品在定向之不同狀態中展現不同的光透射率。因此,可視所施加的電場之強度而定藉由量測樣品之光透射率來控制各別定向狀態以及其配向品質。進而亦有可能確定用以達成特定定向狀態及此等不同狀態之間的轉變所需之電場強度。The samples of the medium according to the invention exhibit different light transmittances in different states of orientation. Therefore, depending on the intensity of the applied electric field, the individual orientation state and its alignment quality can be controlled by measuring the light transmittance of the sample. It is also possible to determine the electric field strength required to achieve a specific orientation state and the transition between these different states.

在根據本發明之介質之樣品中,上述焦點二次曲線狀態由諸多無序雙折射小區域組成。藉由施加高於用於焦點二次曲線結構之成核作用之場的電場(較佳地伴以額外剪切單元)達成均一配向結構,其中螺旋軸在較大、較佳配向之區域中平行於電極平面。根據關於最先進的對掌性向列材料之文獻,諸如P. Rudquist等人,Liq. Cryst.23 (4), 503 (1997),此結構亦稱為均勻橫向螺旋(ULH)結構。需要此結構以表徵發明性化合物之撓曲電特性。In the sample of the medium according to the present invention, the above-mentioned state of the focal quadratic curve is composed of a plurality of disordered birefringent small regions. A uniform alignment structure is achieved by applying an electric field (preferably accompanied by an additional shear unit) that is higher than the field used for the nucleation of the focal quadratic curve structure, where the spiral axis is parallel in the larger, better aligned area On the electrode plane. According to the literature on state-of-the-art palindromic nematic materials, such as P. Rudquist et al., Liq. Cryst. 23 (4), 503 (1997), this structure is also known as the Uniform Lateral Helix (ULH) structure. This structure is needed to characterize the flexural electrical properties of the inventive compounds.

由ULH結構開始,本發明介質可藉由施加電場進行撓曲電切換。此使材料之光軸在單元基板之平面中旋轉,其導致在將材料置放於正交偏光器之間時透射率改變。在以上介紹中及在實例中進一步詳細描述本發明材料之撓曲電切換。Starting from the ULH structure, the dielectric of the present invention can be flexibly switched by applying an electric field. This rotates the optical axis of the material in the plane of the unit substrate, which results in a change in transmittance when the material is placed between the orthogonal polarizers. The flexure electrical switching of the materials of the present invention is described in further detail above and in the examples.

自焦點二次曲線結構開始,藉由向樣品施加具有例如10 kHz之高頻率的電場,同時自各向同性相緩慢冷卻成膽固醇型相且剪切單元,亦有可能獲得ULH結構。對於不同化合物,場頻率可不同。Starting from the focal quadratic curve structure, it is also possible to obtain a ULH structure by applying an electric field having a high frequency of, for example, 10 kHz to the sample, while slowly cooling from an isotropic phase to a cholesterol-type phase and shearing the unit. The field frequency can be different for different compounds.

除在撓曲電裝置中之用途外,根據本發明之介質亦適用於其他類型之顯示器以及其他光學及電光學應用,諸如光學補償或偏光膜、濾色器、反射式膽固醇、旋光能力及光學資訊儲存。In addition to its use in flexural electrical devices, the medium according to the present invention is also suitable for other types of displays and other optical and electro-optical applications, such as optical compensation or polarizing films, color filters, reflective cholesterol, optical rotation ability, and optical Information storage.

無需另外贅述,咸信熟習此項技術者能夠使用以上描述充分利用本發明。因此,以下實例應理解為僅為說明性且無論如何不以任何方式限制本發明之剩餘部分。Without further description, those skilled in the art can use the above description to make full use of the present invention. Therefore, the following examples should be understood as illustrative only and in no way limit the rest of the invention.

除非上下文另有明確指示,否則如本文所使用,術語之複數形式在本文中應被認作包括單數形式,且反之亦然。Unless the context clearly indicates otherwise, as used herein, the plural form of a term shall be considered herein to include the singular form, and vice versa.

在本說明書之描述及申請專利範圍通篇中,詞語「包含(comprise)」及「含有(contain)」及該等詞語之變化形式,例如「包含(comprising)」及「包含(comprises)」意謂「包括但不限於」,且不意欲(且不)排除其他組分。Throughout this description and the scope of the patent application, the words "comprise" and "contain" and variations of these words, such as "comprising" and "comprises" mean Are referred to as "including but not limited to" and are not intended to (and do not) exclude other components.

在本申請案通篇中,應理解結合至三個相鄰原子(例如在C=C或C=O雙鍵中或例如在苯環中)之C原子處的鍵角為120°,且結合至兩個相鄰原子(例如在C≡C中或在C≡N三鍵中或在烯丙基位置C=C=C中)之C原子處的鍵角為180°,除非此等角以其他方式受限(例如如為小環,如3原子環、4原子環或5原子環之一部分),儘管在一些情況下在一些結構式中此等角並非精確呈現。Throughout this application, it is understood that the bond angle at the C atom bonded to three adjacent atoms (for example in a C = C or C = O double bond or for example in a benzene ring) is 120 °, and the bond The bond angle to the C atom of two adjacent atoms (e.g., in C≡C or in the C≡N triple bond or in the allyl position C = C = C) is 180 °, unless such angles start with Other ways are limited (for example, as a small ring, such as a part of a 3-atom ring, a 4-atom ring, or a 5-atom ring), although in some cases these angles are not accurately represented in some structural formulas.

應瞭解,可對本發明之前述實施例作出變化,但其仍在本發明之範疇內。除非另外說明,否則本說明書中所揭示之各特徵可經用於相同、等效或類似目的之替代性特徵置換。因此,除非另外說明,否則所揭示之各特徵僅為一系列通用等效或類似特徵之一個實例。It should be understood that variations may be made to the foregoing embodiments of the invention, but they are still within the scope of the invention. Each feature disclosed in this specification, unless stated otherwise, may be replaced by alternative features serving the same, equivalent or similar purpose. Thus, unless stated otherwise, each feature disclosed is one example only of a generic series of equivalent or similar features.

除至少一些此類特徵及/或步驟相互排斥的組合之外,本說明書中所揭示之所有特徵可以任何組合形式組合。特定言之,本發明之較佳特徵適用於本發明之所有態樣,且可以任何組合予以使用。同樣,在非必需組合形式中所描述之特徵可分別(不以組合形式)使用。All features disclosed in this specification may be combined in any combination other than the mutually exclusive combination of at least some such features and / or steps. In particular, the preferred features of the invention are applicable to all aspects of the invention and can be used in any combination. Also, features described in non-essential combinations may be used separately (not in combination).

在本申請案中所指示之參數範圍均包括極限值,其包括由專家已知之最大容許誤差。彼此組合指示各種特性範圍之不同上限值及下限值產生其他較佳範圍。The parameter ranges indicated in this application all include limit values, which include the maximum allowable errors known by experts. The combination of each other indicates that different upper and lower limits of various characteristic ranges yield other preferred ranges.

根據本申請案之介質中之所有化合物之總濃度為100%。除非另外明確規定,否則所有濃度均以% w/w為單位給出。The total concentration of all compounds in the medium according to this application is 100%. Unless otherwise specified, all concentrations are given in% w / w.

在上述及以下實例中,除非另外指示,否則所有溫度均未經校正以攝氏度闡述,且所有份數及百分比均按重量計。In the above and following examples, unless otherwise indicated, all temperatures are stated in degrees Celsius without correction, and all parts and percentages are by weight.

對熟習此項技術者而言不言而喻,LC介質亦可包含其中例如H、N、O、Cl、F已經對應的同位素置換的化合物。It is self-evident to those skilled in the art that the LC medium may also include compounds in which, for example, H, N, O, Cl, and F have been replaced by corresponding isotopes.

以下縮寫用於說明化合物之液晶相行為:TN,I =澄清點;K =結晶;N =向列型;NTB =第二向列相或扭曲-彎曲向列相;S或Sm =近晶型;Ch =膽固醇型;I =各向同性;Tg =玻璃轉化。符號之間的數字指示以℃計之相變溫度。The following abbreviations are used to describe the liquid crystal phase behavior of the compound: T N, I = clearing point; K = crystalline; N = nematic; N TB = second nematic or twisted-bent nematic; S or Sm = near Crystal form; Ch = cholesterol type; I = isotropic; Tg = glass transition. The number between the symbols indicates the phase transition temperature in ° C.

在本申請案中且尤其在以下實例中,液晶化合物之結構由縮寫(其亦稱為「字首語」)表示。根據下列表A至表C三個表格,可直接將縮寫轉換成對應結構。In the present application and especially in the following examples, the structure of the liquid crystal compound is represented by an abbreviation (which is also referred to as a "word prefix"). According to the three tables A to C below, the abbreviations can be directly converted into corresponding structures.

所有基團Cn H2n+1 、Cm H2m+1 及Cl H2l+l 較佳分別為具有n、m及l個C原子之直鏈烷基,所有基團Cn H2n 、Cm H2m 及Cl H2l 較佳分別為(CH2 )n 、(CH2 )m 及(CH2 )l ,且-CH=CH-較佳分別為反式E 伸乙烯基。較佳,n、m及l表示1與12之間的整數。All groups C n H 2n + 1 , C m H 2m + 1 and C l H 2l + l are preferably straight-chain alkyl groups having n, m and l C atoms, respectively, and all groups C n H 2n , C m H 2m and C l H 2l are preferably (CH 2 ) n , (CH 2 ) m and (CH 2 ) l , respectively, and -CH = CH- is preferably trans E vinyl group, respectively. Preferably, n, m and l represent integers between 1 and 12.

表A列出用於環元素之符號,表B列出用於鍵聯基團之符號,且表C列出用於分子之左側及右側端基之符號。Table A lists the symbols used for the ring elements, Table B lists the symbols used for the linking groups, and Table C lists the symbols used for the left and right end groups of the molecule.

A :環元素


B :鍵聯基團
C 端基

其中n及m各自為整數,且三個點「...」指示用於此表之其他符號之空間。
Table A : Ring Elements


Table B : Linking groups
Table C : End groups

Where n and m are each an integer, and the three dots "..." indicate space for other symbols used in this table.

實例
測試單元及方法
通常在撓曲電混合物處於各向同性相之溫度下在加熱板上填充3 μm厚之單元,該單元在其彼此相對之基板上具有反向平行摩擦PI配向層。
Examples
Test cells and methods <br/> Usually, a 3 μm-thick cell is filled on a hot plate at a temperature where the flexure electrical mixture is at an isotropic phase. The cell has an anti-parallel friction PI alignment layer on its substrate opposite to each other. .

在填充單元之前,通常使用差示掃描量熱法(DSC)測定包括澄清點及結晶行為之相變。此外,對於光學相變量測,使用連接至FP82熱台之Mettler FP90熱台控制器以控制單元之溫度。以5℃/分鐘之速率使溫度自環境溫度上升,直至觀測到各向同性相之起始。經由正交偏光器使用Olympus BX51顯微鏡觀測到結構變化,且記錄下各別溫度。Prior to filling the cell, phase transitions including clarification point and crystallization behavior are usually measured using differential scanning calorimetry (DSC). In addition, for optical phase variable measurement, a Mettler FP90 hot stage controller connected to the FP82 hot stage is used to control the temperature of the unit. The temperature was raised from ambient temperature at a rate of 5 ° C / minute until the beginning of the isotropic phase was observed. Structural changes were observed via an Olympus BX51 microscope through a cross polarizer, and individual temperatures were recorded.

隨後使用銦金屬將線附接至單元之ITO電極。在連接至Linkam TMS93熱台控制器之Linkam THMS600熱台中固定單元。在Olympus BX51顯微鏡中將熱台固定至旋轉載物台。The wire was then attached to the cell's ITO electrode using indium metal. Fix the unit in a Linkam THMS600 hot stage connected to a Linkam TMS93 hot stage controller. The hot stage was fixed to a rotating stage in an Olympus BX51 microscope.

加熱單元直至液晶完全為各向同性。隨後在施加之電場下冷卻單元直至樣品完全為向列型。藉由Tektronix AFG3021B任意函數發生器供應驅動波形,該波形經由Newtons4th LPA400功率放大器發送,隨後施加至單元。用Thorlabs PDA55光電二極體監測單元回應。輸入波形及光學回應均使用Tektronix TDS 2024B數位示波器量測。The cell is heated until the liquid crystal is completely isotropic. The cell is then cooled under the applied electric field until the sample is completely nematic. The drive waveform was supplied by a Tektronix AFG3021B arbitrary function generator, which was sent through a Newtons4th LPA400 power amplifier and then applied to the unit. Response with Thorlabs PDA55 photodiode monitoring unit. The input waveform and optical response were measured using a Tektronix TDS 2024B digital oscilloscope.

為量測材料之撓曲電回應,除非另外明確陳述,否則光軸之傾斜之大小方面之變化作為在35℃溫度下增大的電壓之函數來量測。此藉由使用以下等式來達成:
tan φ = (P0 /2π) (e/K) E
其中φ為光軸自原始位置(亦即當E = 0時)之傾斜,E為施加之場,K為彈性常數(K1 與K3 之平均值)且e為撓曲電係數(其中e = e1 + e3 )。使用HP 34401A萬用表監測所施加之場。使用前述顯微鏡及示波器量測傾斜角。使用附接至電腦之Ocean Optics USB4000光譜儀量測不受干擾膽固醇螺距P0 。獲得選擇性反射帶且根據光譜數據確定螺距。
In order to measure the flexural electrical response of a material, unless explicitly stated otherwise, changes in the magnitude of the inclination of the optical axis are measured as a function of the increased voltage at 35 ° C. This is achieved by using the following equation:
tan φ = (P 0 / 2π) (e / K) E
Where φ is the tilt of the optical axis from the original position (that is, when E = 0), E is the applied field, K is the elastic constant (average of K 1 and K 3 ), and e is the flexural coefficient (where e = e 1 + e 3 ). The applied field was monitored using an HP 34401A multimeter. Use the aforementioned microscope and oscilloscope to measure the tilt angle. An Ocean Optics USB4000 spectrometer attached to a computer was used to measure the undisturbed cholesterol pitch P 0 . A selective reflection band is obtained and the pitch is determined from the spectral data.

以下實例中展示之介質非常適用於ULH顯示器。為此,必須施加所使用的適當濃度之對掌性摻雜劑或摻雜劑以便達成350至275 nm之典型的膽固醇螺距。The media shown in the following examples are very suitable for ULH displays. For this purpose, a suitable concentration of a palmitic dopant or dopant must be applied in order to achieve a typical cholesterol pitch of 350 to 275 nm.

混合物實例
主體混合物 H-1
製備以下混合物H1。使用DSC測定包括澄清點及結晶行為之相變。

Mixture example
Host mixture H-1
The following mixture H1 was prepared. Phase transitions including clearing point and crystallization behavior were determined using DSC.

混合物實例 M-1
15% w/w之化合物BM-1:

添加至85% w/w之主體混合物H-1中。
Mixture example M-1
15% w / w of compound BM-1:

Added to 85% w / w of the host mixture H-1.

將所得混合物M-1均質化且填充至如上文所描述之測試單元中。The resulting mixture M-1 was homogenized and filled into a test cell as described above.

進行關於切換效能、TNI (澄清點)、e/K (柔性彈性常數)及NTB (至第二向列相或向列型扭曲彎曲相之轉變溫度)之量測且結果概述於下表中。
Measurements were performed on switching performance, T NI (clarification point), e / K (flexible elastic constant), and N TB (transition temperature to the second nematic phase or nematic twisted and bent phase) and the results are summarized in the table below. in.

混合物實例 M-2
15% w/w之化合物BM-2

添加至85% w/w之主體混合物H-1中。
Mixture example M-2
15% w / w of compound BM-2

Added to 85% w / w of the host mixture H-1.

將所得混合物M-2均質化且填充至如上文所描述之測試單元中。The resulting mixture M-2 was homogenized and filled into a test cell as described above.

進行關於切換效能、澄清點、柔性彈性常數及NTB 轉變溫度之量測且結果概述於下表中。
Measurements regarding switching efficiency, clarification point, flexible elastic constant, and N TB transition temperature were performed and the results are summarized in the table below.

混合物實例 M-3
15% w/w之化合物BM-3

添加至85% w/w之主體混合物H-1中。
Mixture example M-3
15% w / w of compound BM-3

Added to 85% w / w of the host mixture H-1.

將所得混合物M-3均質化且填充至如上文所描述之測試單元中。The resulting mixture M-3 was homogenized and filled into a test cell as described above.

進行關於切換效能、澄清點、柔性彈性常數及NTB 轉變溫度之量測且結果概述於下表中。


Measurements regarding switching efficiency, clarification point, flexible elastic constant, and N TB transition temperature were performed and the results are summarized in the table below.


混合物實例 M-4
15% w/w之化合物BM-4

添加至85% w/w之主體混合物H-1中。
Mixture example M-4
15% w / w of compound BM-4

Added to 85% w / w of the host mixture H-1.

將所得混合物M-4均質化且填充至如上文所描述之測試單元中。The resulting mixture M-4 was homogenized and filled into a test cell as described above.

進行關於切換效能、澄清點、柔性彈性常數及NTB 轉變溫度之量測且結果概述於下表中。
Measurements regarding switching efficiency, clarification point, flexible elastic constant, and N TB transition temperature were performed and the results are summarized in the table below.

Claims (18)

一種式I之化合物, R11 -A11 (-Z11 -A12 -)p -X11 -Sp11 -X12 -(A13 -Z12 -)q A14 -R12 I 其中 R11 表示NO2 、NCO或NCS R12 表示F、Cl、CN、NO2 、NCO、NCS或直鏈或分支鏈烷基,該直鏈或分支鏈烷基可為未經取代、經鹵素或CN單取代或多取代的且其中一或多個不相鄰且非末端CH2 基團可在每次出現時彼此獨立地經以下基團置換:-O-、-S-、-NH-、-N(CH3 )-、-CO-、-COO-、-OCO-、-O-CO-O-、-S-CO-、-CO-S-、-CH=CH-、-CH=CF-、-CF=CF-或-C≡C-,置換方式為使得氧原子彼此不直接連接, A11 至A14 在每次出現時各自獨立地表示1,4-伸苯基,另外其中一或多個CH基團可經N置換;反-1,4-伸環己基,另外其中一個或兩個不相鄰CH2 基團可經O及/或S置換;1,4-伸環己基;萘-2,6-二基;十氫萘-2,6-二基;1,2,3,4-四氫-萘-2,6-二基,所有該等基團可能為未經取代、經F、Cl、CN或烷基、烷氧基、烷基羰基或烷氧羰基單取代、二取代、三取代或四取代的,其中一或多個H原子可經F或Cl取代, Z11 及Z12 在每次出現時彼此獨立地為單鍵、-COO-、-OCO-、-O-CO-O-、-OCH2 -、-CH2 O-、-OCF2 -、-CF2 O-、-CH2 CH2 -、-(CH2 )4 -、-CF2 CF2 -、-CH=CH-、-CF=CF-、-CH=CH-COO-、-OCO-CH=CH-或-C≡C-,該等基團視情況經一或多個F、S及/或Si取代, p及q 各自且獨立地為0、1、2、3或4, Sp11 為間隔基團,其包含1、3或5至40個C原子,其中一或多個不相鄰且非末端CH2 基團亦可經以下基團置換:-O-、-S-、-NH-、-N(CH3 )-、-CO-、-O-CO-、-S-CO-、-O-COO-、-CO-S-、-CO-O-、-CF2 -、-CF2 O-、-OCF2 -、-C(OH)-、-CH(烷基)-、-CH(烯基)-、-CH(烷氧基)-、-CH(氧雜烷基)-、-CH=CH-或-C≡C-,然而置換方式為使得沒有兩個O原子彼此相鄰且沒有兩個選自-O-CO-、-S-CO-、-O-COO-、-CO-S-、-CO-O-及-CH=CH-之基團彼此相鄰, X11 及X12 彼此獨立地選自單鍵、-CO-O-、-O-CO-、-O-COO-、-O-、-CH=CH-、-C≡C-、-CF2 -O-、-O-CF2 -、-CF2 -CF2 -、-CH2 -O-、-O-CH2 -、-CO-S-、-S-CO-、-CS-S-、-S-CS-、-S-CSS-及-S-,其中在-X11 -Sp1 -X12 -中,兩個O原子、兩個-CH=CH-基團及兩個選自-O-CO-、-S-CO-、-O-COO-、-CO-S-及-CO-O-之基團分別彼此不直接連接。A compound of formula I, R 11 -A 11 (-Z 11 -A 12- ) p -X 11 -Sp 11 -X 12- (A 13 -Z 12- ) q A 14 -R 12 I wherein R 11 represents NO 2 , NCO or NCS R 12 represents F, Cl, CN, NO 2 , NCO, NCS or a straight or branched chain alkyl group, which may be unsubstituted, mono-substituted with halogen or CN Or more substituted and in which one or more non-adjacent and non-terminal CH 2 groups can be replaced independently of each other by the following groups: -O-, -S-, -NH-, -N ( CH 3 )-, -CO-, -COO-, -OCO-, -O-CO-O-, -S-CO-, -CO-S-, -CH = CH-, -CH = CF-,- CF = CF- or -C≡C-, the substitution method is such that the oxygen atoms are not directly connected to each other, and A 11 to A 14 each independently represent 1,4-phenylene, and one or more of them CH groups can be replaced by N; trans-1,4-cyclohexyl, and one or two non-adjacent CH 2 groups can be replaced by O and / or S; 1,4-cyclohexyl; naphthalene- 2,6-diyl; decalin-2,6-diyl; 1,2,3,4-tetrahydro-naphthalene-2,6-diyl, all of which may be unsubstituted, F, Cl, CN or alkyl, alkoxy, alkylcarbonyl or alkoxycarbonyl single , Disubstituted, trisubstituted or tetra-substituted, wherein one or more H atoms may be substituted with F or Cl, Z 11 and Z 12 at each occurrence are each independently a single bond, -COO -, - OCO-, -O-CO-O-, -OCH 2- , -CH 2 O-, -OCF 2- , -CF 2 O-, -CH 2 CH 2 -,-(CH 2 ) 4- , -CF 2 CF 2 -, -CH = CH-, -CF = CF-, -CH = CH-COO-, -OCO-CH = CH-, or -C≡C-, these groups pass one or more F, S as appropriate And / or Si substitution, p and q are each and independently 0, 1, 2, 3, or 4, and Sp 11 is a spacer group that contains 1, 3, or 5 to 40 C atoms, one or more of which are not Adjacent and non-terminal CH 2 groups can also be replaced by the following groups: -O-, -S-, -NH-, -N (CH 3 )-, -CO-, -O-CO-, -S- CO-, -O-COO-, -CO-S-, -CO-O-, -CF 2- , -CF 2 O-, -OCF 2- , -C (OH)-, -CH (alkyl) -, -CH (alkenyl)-, -CH (alkoxy)-, -CH (oxealkyl)-, -CH = CH- or -C≡C-, however the substitution method is such that there are no two O's Atoms are adjacent to each other and no two groups selected from -O-CO-, -S-CO-, -O-COO-, -CO-S-, -CO-O-, and -CH = CH- are in phase with each other Ortho, X 11 and X 12 are independently selected from a single bond, -CO-O-, -O-CO-, -O -COO -, - O -, - CH = CH -, - C≡C -, - CF 2 -O -, - O-CF 2 -, - CF 2 -CF 2 -, - CH 2 -O -, - O-CH 2- , -CO-S-, -S-CO-, -CS-S-, -S-CS-, -S-CSS-, and -S-, where -X 11 -Sp 1 -X In 12- , two O atoms, two -CH = CH- groups, and two selected from -O-CO-, -S-CO-, -O-COO-, -CO-S-, and -CO- The O- groups are not directly connected to each other. 如請求項1之化合物,其中該基團-A11 (-Z11 -A12 -)p -或-(A13 -Z12 -)q A14 -係選自以下式: 其中 CHex 為1,4-伸環己基,Phe為1,4-伸苯基, PheL 為1,4-伸苯基,其經一個、兩個或三個氟原子、經一個或兩個Cl原子或經一個Cl原子及一個F原子取代,且 Z 具有如在部分式II下給出之Z11 之含義中之一者,且若存在兩個,則至少一個係選自-C≡C-、-C=C-、-COO-、-OCO-、-O-CO-O-、-OCH2 -、-CH2 O-、-OCF2 -或-CF2 O-。The compound as claimed in claim 1, wherein the group -A 11 (-Z 11 -A 12- ) p -or-(A 13 -Z 12- ) q A 14 -is selected from the following formula: Where CHex is 1,4-cyclohexyl, Phe is 1,4-phenyl, and PheL is 1,4-phenyl, which has one, two or three fluorine atoms, and one or two Cl atoms Or substituted by a Cl atom and an F atom, and Z has one of the meanings of Z 11 as given under Partial Formula II, and if two are present, at least one is selected from -C≡C-, -C = C-, -COO-, -OCO-, -O-CO-O-, -OCH 2- , -CH 2 O-, -OCF 2- , or -CF 2 O-. 如請求項1或2之化合物,其中Sp11 表示-(CH2 )n -,其中n為1至15之整數,其中一或多個-CH2 -基團可經-CO-置換。For example, the compound of claim 1 or 2, wherein Sp 11 represents-(CH 2 ) n- , where n is an integer from 1 to 15, and one or more -CH 2 -groups may be replaced by -CO-. 如請求項1至3中任一項之化合物,其中 -X11 -Sp11 -X12 - 表示-Sp11 -、-Sp11 -O-、-Sp11 -CO-O-、-Sp11 -O-CO-、-CO-O-Sp11 、-O-CO-Sp11 、-O-Sp11 -、-O-Sp11 -CO-O-、-O-Sp11 -O-CO-、-O-CO-Sp11 -O-、-O-CO-Sp11 -O-CO-、-CO-O-Sp11 -O-或-CO-O-Sp11 -CO-O-,然而限制條件為在-X11 -Sp11 -X12 -中,沒有兩個O原子彼此相鄰,沒有兩個-CH=CH-基團彼此相鄰且沒有兩個選自-O-CO-、-S-CO-、-O-COO-、-CO-S-、-CO-O-及-CH=CH-之基團彼此相鄰。The requested item according to any one of compound 1-3, wherein -X 11 -Sp 11 -X 12 - represents -Sp 11 -, - Sp 11 -O -, - Sp 11 -CO-O -, - Sp 11 - O-CO -, - CO- O-Sp 11, -O-CO-Sp 11, -O-Sp 11 -, - O-Sp 11 -CO-O -, - O-Sp 11 -O-CO-, -O-CO-Sp 11 -O-, -O-CO-Sp 11 -O-CO-, -CO-O-Sp 11 -O- or -CO-O-Sp 11 -CO-O-, however restricted Provided that in -X 11 -Sp 11 -X 12- , no two O atoms are adjacent to each other, no two -CH = CH- groups are adjacent to each other and no two are selected from -O-CO-,- The groups of S-CO-, -O-COO-, -CO-S-, -CO-O-, and -CH = CH- are adjacent to each other. 一種如請求項1之式I之化合物在液晶介質中之用途。Use of a compound of formula I as claimed in claim 1 in a liquid crystal medium. 一種LC介質,其包含一或多種如請求項1至4中任一項之式I之化合物。An LC medium comprising one or more compounds of formula I as claimed in any one of claims 1 to 4. 如請求項6之LC介質,其包含一或多種式II之化合物, R21 -A21 -A22 -(CH2 )a -A23 -A24 -R22 II 其中 R21 及R22 各自且獨立地表示H、F、Cl、CN或直鏈或分支鏈烷基,該直鏈或分支鏈烷基可為未經取代、經鹵素或CN單取代或多取代的,一或多個不相鄰CH2 基團亦可能在每次出現時彼此獨立地經以下基團置換:-O-、-S-、-NH-、-N(CH3 )-、-CO-、-COO-、-OCO-、-O-CO-O-、-S-CO-、-CO-S-、-CH=CH-、-CH=CF-、-CF=CF-或-C≡C-,置換方式為使得氧原子彼此不直接連接, A21 至A24 在每次出現時各自且獨立地表示芳基、雜芳基、脂環族基及雜環基,且 a 表示1至15之整數。If the LC medium of claim 6 comprises one or more compounds of formula II, R 21 -A 21 -A 22- (CH 2 ) a -A 23 -A 24 -R 22 II wherein R 21 and R 22 are each and Independently represent H, F, Cl, CN or a linear or branched alkyl group, which may be unsubstituted, mono- or poly-substituted with halogen or CN, one or more different The ortho CH 2 groups may also be replaced independently of each other by the following groups at each occurrence: -O-, -S-, -NH-, -N (CH 3 )-, -CO-, -COO-,- OCO-, -O-CO-O-, -S-CO-, -CO-S-, -CH = CH-, -CH = CF-, -CF = CF-, or -C≡C-, the replacement method is So that the oxygen atoms are not directly connected to each other, A 21 to A 24 each and each independently represent an aryl group, a heteroaryl group, an alicyclic group, and a heterocyclic group, and a represents an integer of 1 to 15. 如請求項6或7之LC介質,其包含一或多種式III之化合物, R31 -A31 -A32 -(A33 )b -Z31 -(CH2 )c -Z32 -A34 -A35 -A36 -R32 III 其中 R31 及R32 各自且彼此獨立地具有如在式II下針對R21 給出之含義中之一者, A31 至A36 各自且彼此獨立地具有如在式II下針對A21 給出之含義中之一者, Z31 及Z32 在每次出現時各自且獨立地表示-COO-、-OCO-、-O-CO-O-、-OCH2 -、-CH2 O-、-CH2 CH2 -、-(CH2 )4 -、-CF2 -O-、-O-CF2 -、-CF2 CF2 -、-CH=CH-、-CF=CF-、-CH=CH-COO-、-OCO-CH=CH-或-C≡C-,該等基團視情況經一或多個F、S及/或Si取代, c 表示1至15之整數,且 b 表示0或1。If the LC medium of claim 6 or 7 comprises one or more compounds of formula III, R 31 -A 31 -A 32- (A 33 ) b -Z 31- (CH 2 ) c -Z 32 -A 34- A 35 -A 36 -R 32 III wherein R 31 and R 32 each and independently of one another have the meaning given for R 21 under formula II, and A 31 to A 36 each and independently of each other have One of the meanings given for A 21 under Formula II, Z 31 and Z 32 each and each independently represent -COO-, -OCO-, -O-CO-O-, -OCH 2 -, -CH 2 O-, -CH 2 CH 2 -,-(CH 2 ) 4- , -CF 2 -O-, -O-CF 2- , -CF 2 CF 2- , -CH = CH-, -CF = CF-, -CH = CH-COO-, -OCO-CH = CH- or -C≡C-, these groups are optionally substituted with one or more F, S and / or Si, c represents Integer from 1 to 15 and b represents 0 or 1. 如請求項6至8中任一項之LC介質,其包含一或多種式IV之化合物, R41 -A41 -A42 -Z41 -(CH2 )d -Z42 -A43 -A44 -R42 IV 其中 R41 及R42 各自且彼此獨立地具有如在式II下針對R21 給出之含義中之一者, A41 至A44 各自且彼此獨立地具有如在式II下針對A21 給出之含義中之一者, Z41 及Z42 在每次出現時各自獨立地為-COO-、-OCO-、-O-CO-O-、-OCH2 -、-CH2 O-、-CH2 CH2 -、-(CH2 )4 -、-CF2 -O-、-O-CF2 -、-CF2 CF2 -、-CH=CH-、-CF=CF-、-CH=CH-COO-、-OCO-CH=CH-或-C≡C-,該等基團視情況經一或多個F、S及/或Si取代, d 表示1至15之整數。The LC medium of any one of claims 6 to 8, comprising one or more compounds of formula IV, R 41 -A 41 -A 42 -Z 41- (CH 2 ) d -Z 42 -A 43 -A 44 -R 42 IV wherein R 41 and R 42 each and independently of one another have the meaning given for R 21 under Formula II, and A 41 to A 44 each and independently of one another have the same formula as under Formula II One of the meanings given by A 21 , Z 41 and Z 42 are each independently -COO-, -OCO-, -O-CO-O-, -OCH 2- , -CH 2 O -, -CH 2 CH 2 -,-(CH 2 ) 4- , -CF 2 -O-, -O-CF 2- , -CF 2 CF 2- , -CH = CH-, -CF = CF-, -CH = CH-COO-, -OCO-CH = CH-, or -C≡C-, these groups are optionally substituted with one or more F, S, and / or Si, and d represents an integer from 1 to 15. 如請求項6至9中任一項之LC介質,其包含一或多種式V之化合物, R51 -A51 -Z51 -(CH2 )e -Z52 -A52 -(A53 )f -R52 V 其中 R51 及R52 各自且彼此獨立地具有如在式II下針對R21 給出之含義中之一者, A51 至A53 各自且彼此獨立地具有如在式II下針對A21 給出之含義中之一者, Z51 及Z52 在每次出現時各自獨立地為-COO-、-OCO-、-O-CO-O-、-OCH2 -、-CH2 O-、-CH2 CH2 -、-(CH2 )4 -、-CF2 -O-、-O-CF2 -、-CF2 CF2 -、-CH=CH-、-CF=CF-、-CH=CH-COO-、-OCO-CH=CH-或-C≡C-,該等基團視情況經一或多個F、S及/或Si取代, f 表示0或1, e 表示1至15之整數。The LC medium of any one of claims 6 to 9, comprising one or more compounds of formula V, R 51 -A 51 -Z 51- (CH 2 ) e -Z 52 -A 52- (A 53 ) f -R 52 V wherein R 51 and R 52 each and independently of one another have the meaning given for R 21 under Formula II, and A 51 to A 53 each and independently of each other have a formula such as One of the meanings given by A 21 , Z 51 and Z 52 are each independently -COO-, -OCO-, -O-CO-O-, -OCH 2- , -CH 2 O -, -CH 2 CH 2 -,-(CH 2 ) 4- , -CF 2 -O-, -O-CF 2- , -CF 2 CF 2- , -CH = CH-, -CF = CF-, -CH = CH-COO-, -OCO-CH = CH- or -C≡C-, these groups are optionally substituted with one or more F, S and / or Si, f represents 0 or 1, e represents An integer from 1 to 15. 如請求項6至10中任一項之LC介質,其包含一或多種式VI之化合物, R61 -A61 -A62 -(CH2 )g -Z61 -A63 -A64 -(A65 )h -R62 VI 其中 R61 及R62 各自且彼此獨立地具有如在式II下針對R21 及R22 給出之含義中之一者, A61 至A64 各自且獨立地具有如上文在式II下針對A21 給出之含義中之一者, Z61 表示-O-、-COO-、-OCO-、-O-CO-O-、-OCH2 -、-CH2 O、-CH2 CH2 -、-(CH2 )4 -、-CF2 -O-、-O-CF2 -、-CF2 CF2 -、-CH=CH-、-CF=CF-、-CH=CH-COO-、-OCO-CH=CH-或-C≡C-,該等基團視情況經一或多個F、S及/或Si取代, h 表示0或1,且 g 表示1至15之整數。The LC medium of any one of claims 6 to 10, which comprises one or more compounds of formula VI, R 61 -A 61 -A 62- (CH 2 ) g -Z 61 -A 63 -A 64- (A 65 ) h- R 62 VI wherein R 61 and R 62 each have one of the meanings given for R 21 and R 22 under formula II, and A 61 to A 64 have each independently One of the meanings given for A 21 under the formula II, Z 61 represents -O-, -COO-, -OCO-, -O-CO-O-, -OCH 2- , -CH 2 O, -CH 2 CH 2 -,-(CH 2 ) 4- , -CF 2 -O-, -O-CF 2- , -CF 2 CF 2- , -CH = CH-, -CF = CF-, -CH = CH-COO-, -OCO-CH = CH- or -C≡C-, these groups are optionally substituted with one or more F, S and / or Si, h represents 0 or 1, and g represents 1 Integer to 15. 如請求項6至11中任一項之LC介質,其包含一或多種式VII之化合物, R71 -A71 -Z71 -A72 -(Z72 -A73 )j -(CH2 )k -(A74 -Z73 -)l -A75 -Z74 -A76 -R72 VII 其中 R71 及R72 各自且獨立地具有如上文在式II下針對R21 給出之含義中之一者, A71 至A76 各自且獨立地具有如上文在式II下針對A21 給出之含義中之一者, Z71 至Z74 各自且獨立地表示-COO-、-OCO-、-O-CO-O-、-OCH2 -、-CH2 O-、-OCF2 -、-CF2 O-、-CH2 CH2 -、-(CH2 )4 -、-CF2 CF2 -、-CH=CH-、-CF=CF-、-CH=CH-COO-、-OCO-CH=CH-或-C≡C-,該等基團視情況經一或多個F、S及/或Si取代,或表示單鍵,限制條件為Z71 至Z74 中之至少一個不為單鍵, j 表示1至15之整數,且 i及k 表示0或1。The LC medium of any one of claims 6 to 11, comprising one or more compounds of formula VII, R 71 -A 71 -Z 71 -A 72- (Z 72 -A 73 ) j- (CH 2 ) k - (A 74 -Z 73 -) l -A 75 -Z 74 -A 76 -R 72 VII wherein R 71 and R 72 are each and independently have one of the following formula II above in the meaning given for R 21 in Wherein, A 71 to A 76 each and independently have one of the meanings given above for A 21 under Formula II, and Z 71 to Z 74 each independently represent -COO-, -OCO-, -O -CO-O-, -OCH 2- , -CH 2 O-, -OCF 2- , -CF 2 O-, -CH 2 CH 2 -,-(CH 2 ) 4- , -CF 2 CF 2- ,, -CH = CH-, -CF = CF-, -CH = CH-COO-, -OCO-CH = CH-, or -C≡C-, these groups are optionally subject to one or more F, S, and / It is substituted with Si, or represents a single bond, with the restriction that at least one of Z 71 to Z 74 is not a single bond, j represents an integer from 1 to 15, and i and k represent 0 or 1. 如請求項6至12中任一項之LC介質,其包含一或多種對掌性摻雜劑。The LC medium of any one of claims 6 to 12, which comprises one or more palmar dopants. 如請求項6至13中任一項之LC介質,其包含一或多種向列型LC化合物,該等向列型LC化合物選自式X-1至X-4之化合物, 其中 R2A 表示H、具有1至15個C原子之烷基、烯基或烷氧基,另外其中該等基團中之一或多個CH2 基團可各自彼此獨立地經以下基團置換:-C≡C-、-CF2 O-、-CH=CH-、、-O-、-CO-O-或-O-CO-,置換方式為使得O原子彼此不直接連接,且另外其中一或多個H原子可經鹵素置換, L1 及L2 各自彼此獨立地表示F、Cl、CF3 或CHF2 , Z2 及Z2 ' 各自彼此獨立地表示單鍵、-CH2 CH2 -、-CH=CH-、-C≡C-、-CF2 O-、-OCF2 -、-CH2 O-、-OCH2 -、-COO-、-OCO-、-C2 F4 -、-CF=CF-或-CH=CHCH2 O-, p 表示0、1或2, q 表示0或1, (O)Cv H2v+1 表示OCv H2v+1 或Cv H2v+1 ,且 v 表示1至6。If the LC medium of any one of claims 6 to 13, comprising one or more nematic LC compounds, the nematic LC compounds are selected from the compounds of formulas X-1 to X-4, Wherein R 2A represents H, an alkyl group, alkenyl group or alkoxy group having 1 to 15 C atoms, and in addition, one or more CH 2 groups in these groups can be independently replaced with each other by the following groups : -C≡C-, -CF 2 O-, -CH = CH-, , , -O-, -CO-O-, or -O-CO-, the substitution method is such that O atoms are not directly connected to each other, and one or more H atoms can be replaced by halogen, and L 1 and L 2 are independent of each other Ground represents F, Cl, CF 3 or CHF 2 , and Z 2 and Z 2 ' each independently represent a single bond, -CH 2 CH 2- , -CH = CH-, -C≡C-, -CF 2 O- , -OCF 2- , -CH 2 O-, -OCH 2- , -COO-, -OCO-, -C 2 F 4- , -CF = CF- or -CH = CHCH 2 O-, p represents 0, 1 or 2, q represents 0 or 1, (O) C v H 2v + 1 represents OC v H 2v + 1 or C v H 2v + 1 , and v represents 1 to 6. 一種用於製備如請求項6至14中任一項之LC介質的方法,其包含混合一或多種式I之化合物之步驟,其中至少一種化合物選自式II至X之化合物。A method for preparing an LC medium according to any one of claims 6 to 14, comprising the step of mixing one or more compounds of formula I, wherein at least one compound is selected from the compounds of formulas II to X. 一種如請求項6至14中任一項之LC介質在電光學裝置中之用途。A use of an LC medium according to any one of claims 6 to 14 in an electro-optical device. 一種電光學裝置,其包含如請求項6至14中任一項之介質。An electro-optical device comprising a medium according to any one of claims 6 to 14. 如請求項17之電光學裝置,其中該電光學裝置為撓曲電裝置。The electro-optical device according to claim 17, wherein the electro-optical device is a flexure electrical device.
TW107137466A 2017-10-25 2018-10-24 Liquid crystal medium and liquid crystal device TW201923043A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17198332 2017-10-25
??17198332.3 2017-10-25

Publications (1)

Publication Number Publication Date
TW201923043A true TW201923043A (en) 2019-06-16

Family

ID=60182483

Family Applications (1)

Application Number Title Priority Date Filing Date
TW107137466A TW201923043A (en) 2017-10-25 2018-10-24 Liquid crystal medium and liquid crystal device

Country Status (4)

Country Link
CN (1) CN111263799A (en)
DE (1) DE112018005688T5 (en)
TW (1) TW201923043A (en)
WO (1) WO2019081561A1 (en)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1103776C (en) 1996-07-01 2003-03-26 默克专利股份有限公司 Chiral dopants
DE19834162A1 (en) 1997-08-13 1999-02-18 Merck Patent Gmbh Chiral connections
EP0971016B1 (en) 1998-07-08 2003-05-21 MERCK PATENT GmbH Mesogenic estradiols
GB2356629B (en) 1999-10-04 2004-09-22 Merck Patent Gmbh Bimesogenic Compounds and Flexoelectric Devices
GB0225662D0 (en) * 2001-11-16 2002-12-11 Merck Patent Gmbh Liquid crystalline medium and liquid crystal display
GB0402006D0 (en) * 2004-01-30 2004-03-03 Dow Corning Ltd Liquid crystal materials
EP2729549B1 (en) * 2011-07-05 2016-12-07 Merck Patent GmbH Bimesogenic compounds
US20150090935A1 (en) 2012-05-25 2015-04-02 Merck Patent Gmbh Bimesogenic compounds and mesogenic media
EP2870217B1 (en) 2012-07-06 2016-07-20 Merck Patent GmbH Bimesogenic compounds and mesogenic media
EP3044288B1 (en) 2013-09-12 2017-05-17 Merck Patent GmbH Mesogenic compounds and mesogenic media
US10343982B2 (en) * 2013-09-25 2019-07-09 Merck Patent Gmbh Compounds and mesogenic media
WO2015074738A1 (en) * 2013-11-22 2015-05-28 Merck Patent Gmbh Bimesogenic compounds and mesogenic media
JP2017528429A (en) * 2014-07-17 2017-09-28 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung Bimesogenic compounds and mesogenic media
CN107075371B (en) * 2014-11-11 2021-03-12 默克专利股份有限公司 Bimesogenic compounds and mesogenic media
CN107003578B (en) * 2014-12-19 2021-03-23 默克专利股份有限公司 Light modulation element

Also Published As

Publication number Publication date
DE112018005688T5 (en) 2020-07-09
WO2019081561A1 (en) 2019-05-02
CN111263799A (en) 2020-06-09

Similar Documents

Publication Publication Date Title
TWI663247B (en) Mesogenic media and liquid crystal display
EP3248060B1 (en) Light modulation element
TWI611005B (en) Bimesogenic compounds and mesogenic media
TW201625776A (en) Bimesogenic compounds and mesogenic media
TWI645019B (en) Bimesogenic compounds and mesogenic media
TWI697546B (en) Bimesogenic compounds and mesogenic media
TWI691585B (en) Bimesogenic compounds and mesogenic media
TW201617438A (en) Bimesogenic compounds and mesogenic media
TW201932580A (en) Liquid crystal medium and liquid crystal device
JP2019523435A (en) Light modulation element
TWI638880B (en) Bimesogenic compounds and mesogenic media
TW201833307A (en) Liquid crystal medium and liquid crystal device
CN110997870B (en) Liquid crystal medium and liquid crystal device
TW201923043A (en) Liquid crystal medium and liquid crystal device
EP3512920B1 (en) Liquid crystal medium and liquid crystal device
TW201925434A (en) Liquid crystal medium and liquid crystal device
TW201920624A (en) Liquid crystal medium and liquid crystal device
TW201930565A (en) Liquid crystal compound and liquid crystal medium
TWI723090B (en) Liquid crystal medium and liquid crystal device